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Abstract 
 
Anthocyanins (ACs) are powerful antioxidants widely distributed in fruits and vegetables. 
Several international studies suggest that anthocyanins have positive effects on the health, 
including various chronic diseases. To be able to study the possible anthocyanin mechanisms 
in the human body, it is of importance to know their metabolism. MEDOX® is an AC rich 
product made from bilberries and blackcurrant and consists of 17 different anthocyanins with 
delphinidin-3-O-β-glucopyranoside and cyanidin-3-O-β-glucopyranoside as the main 
constituents. There are only 5 different aglycone structures of these 17 anthocyanins; 
delphinidin, cyanidin, peonidin, petunidin and malvidin. An extensive metabolism of ACs is 
indicated following oral administration of this supplement. Free and conjugated benzoic acids 
(BAs) with functional groups corresponding to the anthocyanin B-ring structure have been 
recognized as metabolites in urine and plasma. Correspondingly, gallic acid, protochatechuic 
acids, vanillic acid, syringic acid and 3, 4-dihydroxy-5-methoxybenzoic acid have been 
suggested as metabolites of delphinidin, cyanidin, peonidin, malvidin and petunidin 
respectively. Hydroxy benzoic acids are relatively polar compounds, and derivatization is 
therefore usually necessary prior to gas chromatography mass spectrometry (GCMS) analysis.  
 
The objective of this thesis was to develop a robust analytical method for determination of 
these BAs in addition to 4-hydroxybenzoic acid which is a suggested metabolite of the AC 
pelargonidine. Liquid-liquid extraction (LLE) was chosen as the best sample extraction 
method as compared to solid phase extraction (SPE) and solid phase analytical derivatization 
(SPAD) with respect to recovery, reproducibility and sample purity. LLE was also less time 
consuming than SPE. The recoveries of BAs in urine ranged from 62 – 121 %, and recoveries 
in plasma from 37 – 158 %. All BAs were identified and quantified in urine and plasma after 
oral administration of MEDOX® in increased levels compared to before intake. All 
metabolites were detected as both free BAs and in conjugated form linked with glucuronic 
acid, in both urine and plasma. Results obtained from the work of this thesis suggest that the 
ACs in this product metabolize to their corresponding BAs.  
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1. Introduction 
 
Flavonoids are a common term of numerous polyphenolic compounds found ubiquitously in 
nature. Flavonoids are plant pigments giving color to certain fruits and flowers. The perhaps 
most intriguing aspect of flavonoids are their antioxidant function which holds a potential 
health benefit for humans. The main dietary sources of these antioxidants for humans are 
fruits, vegetables and various beverages. Based on their chemical structure flavonoids are 
categorized into [1-3]: 
 
- Flavones 
- Flavanones 
- Flavonols 
- Isoflavones 
- Catechins 
- Anthocyanidins 
- Chalcones 
 
Anthocyanins (Fig. 1) are a part of the vast flavonoid family, consisting of an aglycone 
(anthocyanidin) part and a glycone (sugar) part. They are a group of naturally occurring 
compounds which are powerful antioxidants. The anthocyanins (ACs) are responsible for the 
color of many fruits, vegetables, and are also found in grain products. As a result, the ACs 
participate in a typical everyday life as a part of the human diet. The intake of anthocyanins in 
humans has been estimated to be 180-215 mg/day, based on numbers from the United States 
of America. This estimate is considerably higher than the intake of other flavonoids, including 
quercetin, kaempferol, myricetin, apigenin and luteolin, which is approximately 23 mg/day [4, 
5]. 
     
    Figure 1. Anthocyanin structure 
 
ACs are perhaps best known as color giving plant pigments, however they have other more 
important features. In plants anthocyanins contribute to the immune system protecting them 
from harmful ultraviolet (UV) rays, and play an important part in the pollination process [6]. 
The main objective for the interest in ACs considering humans is the alleged health benefits 
due to their antioxidant effect. Because of the possibility of ACs being source of several 
health aspects, they have been the target of a number of research projects and studies [7, 8]. 
 
In this thesis, potential metabolites of the anthocyanins containing the six most prominent 
aglycone structures have been studied (Table 1). Five of these aglycone structures with 
different sugars attached, are found in the blueberry and blackcurrant based product 
MEDOX® which has been used as supplement for oral administration to study a possible 
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metabolism of the anthocyanins. The sixth anthocyanin, pelargonidin, should not be found in 
this product. The R5, R6 and R7 groups are the same for all these compounds: OH, H and OH 
respectively [3].   
     
   Table 1. Most common aglycone structures 
Aglycone  R5´  R3´ 
Delphinidin  OH  OH 
Cyanidin  OH  H 
Peonidin  OCH3  H 
Petunidin  OH  OCH3 
Malvidin  OCH3  OCH3 
Pelargonidin H  H 
 
Benzoic acids (BAs) consist of a benzene ring directly bonded to a carboxyl group (Fig. 2). 
BAs can also be called phenolic acids in some cases and vice versa, depending on the 
structure. Benzoic acids always have the acidic group bound directly to the benzene ring; this 
is not always true for phenolic acids. Phenolic acids have a hydroxy (OH) group bound 
directly to the benzene ring, which is not always the case for benzoic acids. The compounds 
sharing these qualities and can be referred to as both, are also often called hydroxy-benzoic 
acids [9].  
 
     
 Figure 2. Benzoic acid structure 
 
Based on research on anthocyanins and metabolic research of ACs, benzoic acids are 
suggested to be metabolites of anthocyanins. The BA metabolite’s functional groups 
correspond to the anthocyanin B-ring structure. These benzoic acids can be found either as 
free or conjugated acids, where in the latter case deconjugation might be necessary for a 
quantitative analysis. The conjugated acids are usually linked to glucuronic acid 
(glucuronidated) and/or sulphuric acid. Methylation is also a common metabolic route, 
allowing some BAs to transform into others [10-15].  
 
The benzoic acids analyzed in this thesis is corresponding to the six most common aglycone 
structures of anthocyanins (Table 2). All the BAs share the qualities qualifying their structures 
as both benzoic and phenolic acids.   
 
 
 
 
 
 
 
Chromatography of metabolites in plasma and urine  
following oral administration of anthocyanin rich capsules 
 
5 
Master thesis: Biological chemistry 
 
Table 2. Analyzed benzoic acids and their parent compounds 
BA  
(chemical name) 
BA 
(abbreviation) 
BA  
(common name)  Parent compound
3,4,5‐trihydroxybenzoic acid  GA  Gallic acid  Delphinidin 
3,4‐dihydroxybenzoic acid  PCA  Protocatechuic acid Cyanidin 
4‐hydroxy‐3‐methoxybenzoic acid  VA  Vanillic acid  Peonidin 
3,4‐dihydroxy‐5‐methoxybenzoic acid DHMBA  ‐   Petunidin 
4‐hydroxy‐3,5‐methoxybenzoic acid  SA  Syringic acid  Malvidin 
4‐hydroxybenzoic acid  HBA  ‐  Pelargonidin 
  
The structures of the suggested hydroxy-benzoic acid metabolites of the selected anthocyanins 
are corresponding to the different AC’s B-ring structure (Fig. 3). 
 
 
Figure 3. Structure of the benzoic acid metabolites analyzed in this thesis 
 
MEDOX® (Fig. 4) is a unique and natural anthocyanin product containing 17 different 
anthocyanins (Biolink Group AS, Norway).  
 
     
    Figure 4. MEDOX® product 
 
MEDOX® is a product combining bilberries (Vaccinum myrtillus) and blackcurrant (Ribes 
nigrum). The molecules believed to have the highest biological potential among ACs are the 
ones possessing a so-called “ortho-dihydroxy phenol” structure. Two of these are cyanidin-3-
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O-β-glucopyranoside (C3G) and delphinidin-3-O-β-glucopyranoside (D3G), which are vastly 
overrepresented in MEDOX®. In fact C3G and D3G accounts for 91 % of the 80 g AC 
content in MEDOX® capsules [16, 17].  
 
Of the 17 different anthocyanins found in MEDOX®, there are only five different aglycone 
structures (Table 3). 
 
Table 3. Anthocyanins found in MEDOX® 
Aglycone     Variations       
structure  3‐O‐β‐glucopyranoside  3‐O‐β‐galactopyranoside  3‐O‐α‐arabinopyranoside  3‐O‐β‐rutinoside 
Delphinidin  x  x  x  x 
Cyanidin  x  x  x  x 
Peonidin  x  x  x    
Petunidin  x  x  x    
Malvidin  x  x  x    
 
Preparation of samples prior to analysis is necessary to make the sample material compatible 
with the instrument utilized. Complex matrixes such as urine and plasma are unfit for direct 
analysis because they contain an excess of biological materials such as protein, salt and cell 
products, making a purification step essential. By applying an extraction method for 
purification, the sample is also allowed to be concentrated. Sometimes extraction alone is 
insufficient and an additional modification is needed, such as derivatization. Derivatization is 
performed on a sample material to make it suitable for the following analysis [18].  
 
Common sample preparation methods for ACs in biological samples are liquid-liquid 
extraction (LLE) and solid phase extraction (SPE) following pretreatment of deconjugation in 
most cases [7, 8, 10, 19-23]. 
 
Chromatography is defined as a process for separating compounds in a mixture. The term 
chromatography is collective for several separation techniques, for which the principle is to 
separate analytes by distribution over two phases, a mobile phase and a stationary phase. The 
mobile phase is either a liquid or gas; hence the names liquid chromatography (LC) and gas 
chromatography (GC) [18].   
 
For the separation, detection and analysis including identification and quantification of the 
compounds in this thesis, capillary gas chromatography coupled with mass spectrometry 
(GCMS) was chosen. GCMS was considered a good choice due to the techniques separation 
and identification qualities [24, 25]. Various separation techniques have been used for separation 
and identification of phenolic compounds, mainly HPLC and GC [7, 8, 10, 19-23]. Capillary 
electrophoresis (CE) has also been utilized for separation of phenolic compounds, however it 
is not common [26].  A common advantage when applying techniques such as HPLC and CE, 
compared to GC, is that these methods do not usually require a derivatization step before 
quantitative analysis which can be quite time consuming. This argument is contributing to the 
choice of HPLC as the most commonly used method for qualitative and quantitative analysis 
of plant phenolic compounds. The detector principles used with HPLC is typically UV, 
electrochemical and fluorescence [10, 15, 18]. Because the UV/Vis spectrum does not supply 
sufficient identifying power, and HPLC does often not provide sufficient separating 
performance, GCMS is a good choice of method for analysis of phenolic compounds [24, 25, 27].  
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The overall aim of the thesis is the development of a robust chromatographic method for 
determination of selected metabolites in urine and plasma following oral administration of 
MEDOX®. The selected metabolites are free and glucuronic acid conjugated benzoic acids: 
 
 
- 3,4,5-trihydroxybenzoic acid (GA) 
- 3,4-hydroxybenzoic acid (PCA) 
- 4-hydroxy-3-methoxybenzoic acid (VA) 
- 3,4-dihydroxy-5-methoxybenzoic acid (DHMBA) 
- 4-hydroxy-3,5-dimethoxybenzoic acid (SA), and: 
- 4-hydroxybenzoic acid (HBA) 
 
The first five of these benzoic acids, respectively, are expected metabolites from the 
MEDOX® supplement; whereas the last acid (HBA) is an expected metabolite from 
pelargonidine which is an anthocyanin found in strawberries amongst others.  
 
Based on the results acquired by the use of the developed optimized method, there should be 
possible to discuss whether these benzoic acids really are metabolites of the anthocyanins 
found in MEDOX®.  
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2. Theory 
 
2.1 Anthocyanins 
 
Anthocyanins are of great interest because of their alleged antioxidant activity. They are part 
of the flavonoid family which are synthesized from phenylalanine and are characterized by a 
benzo- γ-pyrone structure [2]. The skeletal carbon structure (Fig. 5) possessing 15 carbon 
atoms; two benzene rings joined by a linear three carbon chain, can be described as C6-C3-C6, 
containing three phenolic rings called A, B and C. The C-ring can also rarely consist of two 
carbon atoms.  Usually the B-ring is in 2 position of the C-ring; however it can also be located 
at position 3 and 4 [2, 28]. 
     
    Figure 5. General flavonoid structure 
  
Phenols and polyphenols, including flavonoids and ACs, are effective antioxidants since the 
radical products of these molecules are resonance stabilized and thus relatively stable [29]. It is 
believed that ACs have positive effects on several health aspects also in a preventive way. 
The metabolism and bioactivity of these antioxidants are two features of great importance to 
study to understand their effect. 
 
2.1.1 Biosynthesis and metabolism 
The anthocyanin biosynthesis is also often called the flavonoid pathway since other 
flavonoids are also synthesized by this pathway. The ACs are assembled by two separate 
biosynthesis paths which result in the amino acid (AA) phenylalanine (Fig. 6) and malonyl-
coenzyme A (coA) (Fig. 7) which are both essential in the joined synthesis of anthocyanins [3, 
6, 29-31].  
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Figure 6. Synthesis of the amino acid phenylalanine, the starting point of AC     
      biosynthesis 
 
The abbreviations ATP, ADP and P in the figure above (Fig. 6) stand for adenosine 
triphosphate, adenosine diphosphate and phosphate respectively. ATP functions as a 
coenzyme and is often used for energy transfer in the cells for metabolism. ATP is 
transformed to ADP by phosphorylation [29, 30]. The Shikimate pathway leads from PEP and 
E4P to chorismate. Chorismate is thereafter used as substrate to form the aromatic AAs 
phenylalanine, tyrosine and tryptophan. Only phenylalanine is involved in the synthesis of 
flavonoids and ACs. Phenylalanine synthesis from L-Arogenate is the characteristic route in 
higher plants. Some bacteria form the aromatic AAs directly from prephenate [3, 32].  
 
    
Figure 7. Synthesis of Malonyl-CoA, which is needed for AC synthesis 
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Acetyl-CoA carboxylase (ACCase) is the enzyme which transforms Acetyl-CoA into 
Malonyl-CoA which is used further for AC synthesis [29, 30]. The two separate streams 
resulting in phenylalanine and malonyl-CoA meet and are enzymatically joined together by 
chalcone synthase (CHS), generating a transitional chalcone which is isomerized to the 
flavonone naringenin. Anthocyanin production happens in plants through a series of 
enzymatically assisted steps which constitutes the anthocyanin biosynthesis (Fig. 8) [3, 6, 31]. 
 
  
Figure 8. Anthocyanin (flavonoid) biosynthesis, abbreviations explained in the text 
 
Phenylalanine ammonia-lyase (PAL) is the first enzyme involved in the biosynthetic pathway 
of ACs. PAL leads to the cleavage of the amino-group of phenylalanine which is released as 
ammonium which is utilized in glutamine synthetase. Glutamate and glutamine serve as 
nitrogen donor to chorismate in the pathway leading to phenylalanine. Transcription of the 
PAL gene is enhanced by light, plant growth regulation as wounding (excision) and different 
types of stress. For instance have stressful light conditions such as high UV-radiation proved 
to increase flavonoid and AC production in plants which serve as the plants protection from 
UV damage. It has also been suggested that nutritional depletion in plants also enhance the 
transcription of the PAL gene enabling AC synthesis. The other enzymes shown between the 
steps in the figure (Fig. 8) is cinnamate 4-hydroxylase (C4H), 4-coumarate-CoA ligase (4CL), 
chalcone synthase (CHS), chalcone isomerase (CHI), flavonone 3-hydroxylase (F3H), 
flavonoid 3´-hydroxylase and flavonoid 3´,5´-hydroxylase (F3´H, F3´5´H), flavonol synthase 
(FLS), leucoanthocyanidin reductase (LAR), dihydroflavonol 4-reductase (DFR), 
anthocyanidin synthase (ANS), glycosyltransferase (GT), acyltransferase and 
malonyltransferase (ACT,MAT) [3, 6, 31]. 
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The anthocyanidin forms are unstable and by glycosylation they become anthocyanins and are 
stabilized. There are a great number of sugar conjugations possible but the most common are: 
glucose, galactose, rhamnose, arabinose and xylase. Glycosylation of the anthocyanidin is 
what forms the AC since it is where the sugar group is added. If acylation or malonylation 
occur, it happens after the glycosylation. Anthocyanins are water soluble pigments caused by 
the presence of sugar. In case the sugar moiety is hydrolyzed or lost, the solubility will 
decrease and the aglycone will be destabilized or degraded. Acylation and malonylation 
increase the water solubility of the molecule [3, 6, 33]. 
 
Keppler et al. employed a new in vitro model system, to investigate the question of 
deglycosylation, ring scission, and other bacterial degradation pathways of anthocyanins. 
They used a naturally composed gut flora directly isolated from the caecum of freshly 
slaughtered pigs, excluding any aerobic atmosphere. Their results clearly show that 
anthocyanidin glycosides were hydrolyzed extensively by the intestinal micro flora depending 
on the sugar moiety. After cleavage of the protective 3-glycosidic linkage, the released 
aglycones are very unstable under physiological conditions in the intestine at neutral pH and 
degrade spontaneously into phenolic acids and aldehydes. Anthocyanidins were released by 
hydrolysis of ACs. The decay of the aglycone (anthocyanidin) cyanidin led to protocatechuic 
acid (PCA), peonidin degraded into vanillic acid (VA), and syringic acid (SA) was detected as 
the degradation product of malvidin. There was also O-demethylation, with the formation of 
two other metabolites; SA was O-demethylated into gallic acid (GA), and VA converted to 
PCA. The cleavage of methyl groups and liberation of free hydroxyl groups modulate the 
antioxidant properties of these phenolic compounds. It is believed that, because of their higher 
chemical and microbial stability, phenolic acids (hydroxy-benzoic acids) identified as AC 
metabolites, might be mainly responsible for the observed antioxidant activities and other 
physiological effects in vivo and not just the anthocyanins themselves [11]. 
 
2.1.2 Biological effects 
 
Studies show that anthocyanins have substantial bioactivity, including antioxidant activity, 
and therefore may have beneficial effects on human health [11, 21]. Dietary ACs’ presumed 
ability to influence biological systems could be partly due to their characteristic ability to 
form complexes with macromolecules, combined with their polyphenolic nature. ACs is 
showed to have a role as scavenger of harmful free radical which cause oxidative damage to 
nucleic acids, proteins and lipids, in addition to have potential interaction with biological 
systems. ACs have been shown to have reactivity towards both reactive oxygen and nitrogen 
in vitro [7, 14, 25]. Reports of health beneficial effects have been shown in humans and also 
experimental animals. The effects of ACs are many and diverse, ranging from antioxidant 
behavior to cancer prevention and inhibition. Vision improvement is one function of ACs 
where they have a regenerating effect of rhodopsin which is a pigment of the retina for 
formation of photoreceptor cells. Apoptotic effects (programmed cell death) of 
anthocyanidins and ACs in cancer cells have been reported both in vitro and in vivo, in 
addition to tumor decrease, and inhibition of tumorigenesis in rats. Anticarcinogenic effects 
altering metabolic activation of carcinogens are also reported [8, 11, 14, 22, 34, 35]. There are also 
studies suggesting that ACs have protective and preventive effects on cardiovascular diseases 
and atherosclerosis. Atherosclerosis is a condition causing chronic inflammatory response due 
to thickening of the arterial wall as the result of for instance cholesterol and other fatty 
materials. Other functions of the health beneficial effects of ACs are suggested to be anti-
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inflammatory effects, reduced risk of stroke and diabetes, anti-obesity effects and anti-
mutagenic action against various mutagens. In addition to this they are also believed to protect 
against DNA damage and prevent low-density lipoprotein oxidation and inhibition of platelet 
aggregation [10, 35-37]. 
  
As ACs play a natural part in the daily diet of humans, these discoveries are of high interest 
and importance to pursue. Knowledge of ACs for prevention of chronic diseases is of great 
importance for humans as ACs are easily available as food and beverages. To be able to study 
these effects further also other aspects of these phenolic compounds are needed to research. 
The bioavailability and metabolism of the anthocyanins are necessary to study in order to 
understand more of the biological effects of ACs due to dietary intake.  
 
2.1.3 Bioavailability 
 
To begin to understand the health benefits caused by anthocyanins and the extent of these, 
there is a need to understand more concerning the bioavailability of ACs in humans. In order 
to exert an effect in vivo, a dietary compound has to reach tissues, in the native or 
metabolized form, in a dose sufficient to yield biological effects [12]. To achieve an effect in a 
target organ or tissue (except the GI tract), bioactive components must be bioavailable. 
Evaluating the health benefits of ACs in humans, the bioavailability, including the absorption, 
distribution, metabolism and excretion, must be known [21, 36]. ACs have two absorbance 
maxima, 279-280 nm and 510-540 nm [5], a fact which is utilized when trying to detect these 
compounds. The most common naturally occurring ACs are the following: 3-O-glucosides or 
3, 5-di-O-glucosides of cyanidin, delphinidin, peonidin, petunidin and malvidin. Several 
studies have shown that ACs are absorbed as glycosides in humans, and in experimental 
animals such as rats [1, 5, 21, 22, 37, 38]. The intact glycosidic forms have indeed been recovered in 
plasma and urine after oral administration, with one drawback [4]. The bioavailability was 
thought to be very low and considering the metabolism was not, and is still not, fully 
understood, the phenolic acid metabolites were not considered at that point. The recovery, of 
the formerly only known, metabolites (glucuronidated and methylated compounds) in urine 
and plasma has been found to be below 1 %, whereas up to 99 % if the ingested anthocyanins 
is eliminated in the gut [12].  
 
The supposed low bioavailability of anthocyanins contradicted the explanation of the 
antioxidant properties of AC rich food as a major health benefit contributor. The results of 
low absorption values compared to the ingested dosage in humans and animals led to the 
indication of an extensive biotransformation of the ACs after oral ingestion and absorption. In 
a study, protocatechuic acid (PCA) was retrieved as the main metabolite of cyanidin 
glycosides (CyG). These results showed consistency with former studies, recovering less than 
1 % methylated or glucuronidated AC in blood and urine. PCA, however, was found as the 
main metabolite in serum and it accounted for 44 % of ingested CyG in the following 6 hour 
period after ingestion. No PCA was recovered in urine, and the native AC and glucuronidated 
and methylated compounds seemed to be most common. In other studies, PCA has been 
found in trace amounts in both plasma and urine, unsuspectingly of the source. One study 
found PCA in concentrations 8-fold higher than that of the native AC itself. In another study, 
however, PCA was suggested not to be the metabolite of CyG. Despite these discrepancies, 
PCA was reported as an AC metabolite, and gave way for the possibility of other phenolic 
acids as metabolites [11-14, 21]. 
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2.2 Chromatography 
 
Chromatography is a common name for several separation techniques in chemical analysis. 
Even though there are different forms of chromatography, they are all based on the principle 
that the compounds separated are dispersed between two phases; one of them is mobile while 
the other is stationary. Depending on the method, the mobile phase can either be a liquid or a 
gas, inspiring the names liquid- (LC) and gas chromatography (GC).  
 
Chromatography can separate gases and volatile substances by GC, non-volatile chemicals 
and materials of high molecular weight by LC, and also by the inexpensive planar thin layer 
chromatography (TLC). GC and LC are both column chromatography methods. 
 
In one single process, chromatography can separate a mixture into its individual components, 
and with an appropriate detector connected identify and quantify each compound. There are 
of course some restrictions and a need for sample preparation work before an analysis. A 
column chromatography system consists of the following main components: Mobile phase, 
pump, column, detector and data treatment (Fig. 9). 
 
Figure 9. Column chromatography system 
 
The selection of the right combination of several separation factors is crucial to the separation 
of a mixture of compounds:  
 
- Stationary and mobile phase 
- Length and diameter of column 
- Mobile phase velocity 
- Sample size 
 
The properties of a compound determine the velocity of which the compound moves through 
the column. The differences between the diverse compounds in a sample make them migrate 
at different velocities. It is the compounds equilibrium distribution between the two phases 
that determine the migration velocity. Without this difference there would be no separation.  
 
A sufficient separation is the goal when using chromatography. Resolution (R) is a 
quantitative measurement for separation. When R has the value of 1, there is 2 % overlap 
between two peaks. A higher value than 1 indicates a better separation, and a lower value 
means poorer separation.  
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In order to detect the compounds separated with chromatography, a suitable detector is 
needed. There are several detector possibilities, depending on chromatographic technique and 
compounds of interest [18]. 
 
2.2.1 Gas chromatography 
Gas chromatography use gas as its mobile phase which is usually called the carrier gas and is 
stored in a high pressure cylinder. To be able to analyze compounds with GC, the compounds 
need to be volatile and stable at the temperatures employed by the system. There are two 
kinds of gas chromatography: 
- Gas-solid chromatography (GSC) 
- Gas-liquid chromatography (GLC) 
GLC is the chromatography type used for most GC analyses. There are several nonvolatile 
compounds that can be separated with both GC and LC but these need to be derivatized 
before GC separation. The capillary columns in GC have as a rule far higher separation 
efficiencies than LC columns. Consequently, GC can handle multi-component mixtures more 
easily.  
 
The purpose of the carrier gas in the chromatographic system is to transport volatile 
substances through the column. The most common gases used are helium, nitrogen and 
hydrogen, which are all inert and will not react with the sample or the stationary phase.  
 
Most samples analyzed with GC are fluids which are injected with a syringe often in volumes 
of 1 µl or less. There are three types of columns for GC; preparative, analytical and capillary 
[18]. 
 
2.2.2 Detectors 
For GC there are several detectors which can be employed, and these can all be classified 
within two main types: 
 
1) Concentration sensitive detectors  
2) Mass sensitive detectors 
 
More than 15 years ago, some of the most commonly used detectors were the thermal 
conductivity detector (TCD) and the flame ionization detector (FID), type 1 and 2 
respectively. During the last two decades mass spectrometry (MS) has increased its impact, 
and is today the most commonly used detector in combination with gas chromatography 
(GCMS) [18]. 
 
2.2.3 Mass spectrometry 
 
A mass spectrometer (MS) is a mass selective detector and fits in under type 2 of GC 
detectors. A mass spectrometer consists of an ion source, a mass analyzer and a detector. One 
of the most frequently used ion sources are electron ionization (EI). When the separated 
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compounds enter the EI ion source, a bombardment of electrons hit the molecules resulting in 
formation of charged molecules and charged fragments (Fig. 10). The charged molecules 
and/or fragments enter the mass analyzer by the force of electrically charged lenses. Both 
negatively and positively charged ions are formed in the ion source. However, it is not 
common to detect negative ions due to the increased sensitivity for positive ionization mode 
(EI+). Fragmentation is the result of the excess energy in the molecule [18, 39, 40].   
 
 
Figure 10. Illustration of EI reaction creating charged molecules and ion fragments 
 
Several different types of ionization and various mass analyzers can be chosen. The selection 
of these components is dependent on the use of the MS. The purpose of MS is to separate the 
ions based on their mass-to-charge ratios (m/z) and to detect these qualitatively and 
quantitatively [18, 40]. 
 
Apart from EI, there are other common ionization methods in the gas phase, such as [40]:  
 
- chemical ionization (CI) 
- field ionization (FI) 
- photo ionization (PI) 
- multi photon ionization (MPI) 
 
Mass analyzers differ with regard to how m/z values are separated, and can be used alone or 
in combination (MSMS and MSn). The most commonly used mass analyzers are [18, 39, 40]:  
 
- Magnet instrument 
Ions with different m/z values are separated in a magnetic field by varying the field.  
 
- Quadrupole instrument 
The analyzer consists of four parallel circular rods. Ions are separated in the quadrupole 
based on the stability of their trajectories in the oscillating electric fields that are applied 
to the rods. In GCMS combination, mainly quadrupole instruments are used because their 
mass area covers the molecular weights for the compounds which can be applied to GC. 
 
- Ion trap instrument 
The separation happens by a corresponding principle as in the quadrupole instrument. In 
contrast to a regular quadrupole instrument, the ion source and the analyzer is combined 
in one common unit. 
 
- Time-of-flight (TOF) instrument 
Often used in combination with HPLC but not for GC. Ions accelerate in pulses before 
they are led through a drift tube where they receive the same kinetic energy and move 
through the tube with a velocity equivalent to the square root of their mass.  
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- Ion cyclotron resonance 
The ions are accelerated in a cyclotron and separation occur based on cyclotron frequency 
of the ions in a fixed magnetic field.  
 
Using a mass spectrometer as detector enables structural information, and the possibility of 
identification, of the analytes in addition to quantification. There are two modes one can 
obtain mass spectra with; scan mode or single ion monitoring (SIM) mode. Scan is usually 
used for identification and SIM for quantification. Continuously scanning the magnetic field 
exponentially downward from high to low mass keeping the accelerate voltage constant is 
called “scan” mode. Scan is typically chosen to obtain a mass spectrum of the whole m/z 
range, and produces mass spectral peaks of constant width. Peak width is inversely 
proportional to the resolving power, which is the ability of the MS to separate ions of adjacent 
mass number. The mass spectrum is a histogram plotted as relative intensity of ions as a 
function of m/z values.  
 
When components are known or suspected to be found, the full spectrum is not necessary to 
detect. The MS instrument can also be programmed to detect only one or a few masses, this is 
called SIM mode. SIM mode requires that the spectrum of the target compounds are known so 
that the most characteristic masses can be chosen; selecting the right masses for SIM 
improves the sensitivity. When masses are chosen for SIM detection, a qualifier (identifier) 
and quantifier ion is chosen. The identifier ion should ideally be unique for a compound, and 
the quantifier ion should be the most prominent peak in the mass spectra with the highest 
intensity compared to the other compound peaks. These criteria ought to be followed to 
achieve a good foundation for a SIM method [18, 40].  
 
2.2.3.1 Typical fragmentation of benzoic acid trimethylsilyl derivatives by electron ionization 
 
The combination of GC and MS (or MSMS) is a powerful analytical technique for 
identification and quantification of compounds in complex mixtures. By coupling GC directly 
to the MS, the carrier gas containing the analytes enters directly into the ion source. Ionization 
can occur since the analytes are volatile and in gas phase. 
 
Sample preparation prior to GCMS analysis of compounds such as BAs involves 
derivatization to make the compounds compatible with the instrument. A common 
derivatization method is silylation creating trimethylsilyl derivatives (TMS) of the compounds 
in question. By the use of EI as ionization mode, there are several typical ion fragments found 
in the mass spectra (Table 4).  
 
Table 4. Common ions/ion fragments found in mass spectra of BA TMS derivatives 
Ions/ion fragments  Explanation 
[M]+  Molecular ion (positive charge) 
[M‐15]+  Loss of a methyl group via α‐cleavage 
[M‐30]+  Loss of a formaldehyde molecule 
[M‐59]+  Subsequent loss of CO2 after rearrangement 
[M‐89]+  Loss of trimethylsiloxyl (TMSO) 
[M‐177]+  Loss of TMSO‐Si(CH3)4  
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The molecular ion is usually a predominant peak in all BA mass spectra. For TMS esters 
generation of the fragments [M-15]+ and [M-59]+ are common. The fragment [M-30]+ is 
produced by derivatives possessing a methoxy group on the phenyl ring. [M-89]+ is an 
established fragmentation pathway for carboxylic acids, because the acylium cation formed is 
a stable species. The fragment [M-177]+ is most common for derivatives with two or more 
TMS groups attached in adjacent positions [24, 41].  
 
Other than the m/z values for the molecular ions and ion fragments, the fragment m/z 73 is 
commonly observed as the base peak in mass spectra for TMS derivatives, representing the 
TMS group. The fragment m/z 147 can also be found in such mass spectra, representing the 
structure [(CH3)2Si=O-Si(CH3)3]+ which means there is two or more TMS groups present in 
the molecule [24]. 
 
2.2.4 Internal standard 
 
An internal standard (IS) is a substance added to a sample in a known quantity to make it 
possible to correct certain factors. The IS is an essential component in developing a robust 
analytical method, and its role is to function as a correction for: 
 
- loss during sample preparation 
- differences in injected volume 
- differences during a chromatographic analysis 
- change in response factor 
 
During sample preparation there can be loss of sample volume during several steps, for 
instance by use of pipettes and evaporation of solvent. The internal standard has to be added 
to the sample solution before the preparation starts. 
 
More than one internal standard may be added to the sample, in case there are multiple 
substances with different chemical properties which are supposed to be detected in a sample. 
In order to quantify compounds in a sample, a standard calibration curve is needed. A 
standard curve is prepared by an analysis of known amounts of the substances and the internal 
standards. The area ratio of substance/IS or peak height ratio of substance/IS is plotted against 
the concentration ratio[18].  
 
Equation for a linear calibration curve is: 
 
x = (y-b) / a           (1) 
         
Concentration of target compounds are found by this equation: 
 
Conc. compound = (Conc. IS x Compound area) / IS area   (2) 
 
 
There are several criteria that needs to be filled when selecting an internal standard [18]:  
 
- it has to be separated from the rest of the substances in a given sample, either by time  
 in the chromatogram or by mass in the mass spectra 
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- the retention time must be similar to the chosen substance that is going to be 
 quantified 
- similar chemical properties as the chosen substance, which is especially important 
 throughout the sample preparation step such as extraction and derivatization 
- it must not be present in the sample 
- it has to be stable and not react with anything in the sample (or the stationary/mobile 
 phase) 
- it needs to be of high purity 
 
A good choice in internal standard is therefore a substance as similar to the substance you 
want to quantify as possible. One possibility is to utilize an isotopically labeled version of the 
target substance. Because of the abundance in hydrogen atoms in organic molecules, 
deuterium is generally the preferred isotope to use to make isotopically labeled internal 
standards. A deuterated IS is nearly identical to the substance itself except for its molecular 
weight which will increase with +1 for each deuterium attached to the substance. Ideally the 
deuterated IS has the same recovery, very close retention time and the same ionization 
response, as the unlabeled substance [42].  
 
2.3 Sample preparation 
 
Sample preparation is performed before analysis to make a sample suitable for the selected 
analytical technique. However, before the sample preparation methods can be done, the 
sample matrix often needs to be somewhat adjusted. Before extraction, a sample might need 
to be adjusted to the right pH value for the compounds to be able to move to the right phase. 
Often, and especially in biological matrixes, compounds are conjugated with highly polar 
molecules, such as glucuronic acid or sulfuric acid. When the total amount of a compound is 
required, deconjugation by hydrolysis might be a necessary pretreatment step [10, 15, 18]. 
 
Sample preparation is used to purify and concentrate the compounds of interest prior to 
analysis. The purification usually includes separation of target compounds from the matrix 
and transference to a solvent which is compatible with the analytical method. 
 
Sample preparation is usually necessary because of the following reasons [18]: 
 
- the sample matrix is incompatible with the separation method, and would hamper 
 good analytical quality 
- the compounds of interest cannot be analyzed with a satisfactory result because of 
 interference of other compounds in the sample 
- the concentration of the compounds are below the instrumental limits of detection 
 
The most frequent used sample preparation methods are two extraction techniques [18]: 
 
- liquid-liquid extraction (LLE) 
- solid phase extraction (SPE) 
 
In some cases a simple extraction method for sample preparation is not sufficient prior to 
analysis of the compounds. Derivatization is chemical modification of a compound, and is 
often used to increase volatility prior to GC analysis or improve LC detection limits by 
addition of an appropriate chromophore. The derivatization process chemically modifies one 
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compound to produce a new compound which has the suitable properties for the analysis [43]. 
In high pressure liquid chromatography (HPLC) derivatization is not a necessity but it can be 
utilized to enhance sensitivity and sometimes also affect the selectivity and solubility. For 
GC, which is the chromatography method used in this thesis, derivatization is used to make 
compounds more volatile and less polar.  
  
2.3.1 Liquid-liquid extraction (LLE)  
 
Liquid-liquid extraction is an extraction method based on how compounds distributes in two 
immiscible liquids. Usually, one phase is an aqueous hydrophilic solution, and the other a 
hydrophobic organic solvent. The sample is the hydrophilic solution and the solvent added 
needs to have the right properties so that the compounds of interest will transfer over to this 
phase. To efficiently extract the desired compounds from one phase to another, a sequence of 
two or three extractions with the chosen solvent is performed [18, 44]. 
 
The dispersion of a compound in two immiscible liquids can be well described by the 
equilibrium constant (K) for the given compound at a fixed temperature, ion strength and pH 
[18]: 
 
KLLE = [I]L1 / [I]L2          (3) 
 
where [I]L1 and [I]L2 is the two immiscible liquids. If the characteristics of one solvent change 
the equilibrium constant K changes likewise. To extract a compound from one phase to 
another the K value is optimized by the choice of solvent, pH and ion strength. 
 
The density of a solvent should not have a higher value than water for the practical benefit of 
an extraction. It should also be noted that several extractions with smaller volumes yields 
higher efficiency than extracting once with an equivalent large volume. To concentrate a 
sample after extraction, the sample is often evaporated, calling for a volatile solvent to be 
employed for extraction [18, 44]. 
 
2.3.2 Solid phase extraction (SPE)  
 
In contrast to LLE, the compound is in the case of solid phase extraction not transferred to 
another liquid phase but to a solid surface, a sorbent. SPE is used with the same purpose as 
LLE, to isolate, purify and concentrate compounds in liquids [18, 45]. 
 
Equilibrium is formed when the compound is distributed between the liquid sample and the 
sorbent, either by adsorption to the surface or penetration of the outer layers of the molecules 
on that surface. An equilibrium constant can also be described for SPE as for LLE: 
 
KSPE = [I]S1/[I]L1          (4) 
 
However, if the dispersion process occurs in a SPE column packed with a sorbent, which is 
usually the case, a different approach to the equilibrium constant is needed and a different 
equation applies:  
 
k = 1/(1-k’) or: V0/VR          (5) 
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where V0 and VR is the void volume in the column and the retention volume respectively [45].  
 
If a compound is to be isolated on the surface of a sorbent, the surface needs to have chemical 
groups which will have a stronger interaction with the compound than the interaction between 
the compound and the liquid.  
 
There are different packing materials and extraction principles with SPE, the most common 
are [18, 45, 46]: 
 
- Reversed phase extraction 
Used to extract non-polar or weakly polar compounds. It separates analytes based on their 
polarity, retaining compounds by hydrophobic interactions. The extraction is based on 
interaction between the carbon-hydrogen bonds in the compound and the carbon-hydrogen 
bonds on the sorbent. It involves a polar or moderately polar sample matrix and a nonpolar 
stationary phase (solid phase). 
 
- Normal phase extraction 
Used to extract polar compounds from non-aqueous solutions. It involves a nonpolar liquid 
phase (sample matrix) and a polar solid phase. The principle is based on polar interactions 
between the compounds and sorbent such as hydrogen bonds, dipole-dipole interaction and 
other interactions caused by positive and negative charge differences. Normal phase 
extraction retains compounds based on hydrophilic interaction. 
 
- Ion exchange  
Used to isolate ionized compounds from aqueous solutions. The extraction is based on the 
ionic interactions between sorbent. Anion exchange is based on positively charged functional 
groups interacting and retaining negatively charged anions (acids), while cation exchange has 
negatively charged functional groups interacting and retaining positively charged cations 
(bases). 
 
Silica based sorbents are perhaps the most commonly used sorbent for reversed phase, normal 
phase and ion exchange columns. Its characteristics inhibit swelling and shrinking in various 
solvents resulting in faster equilibration in new solvents. The surface chemistry of silica based 
packing material is the presence of hydroxide groups (silanols), and it is an inorganic polymer 
with the general formula (SiO2)x. Pore size is usually around 60 Angstrom (Å), prohibiting 
large molecules from entering the pores, however the pore size ranges from 50-500 Å [18, 45].   
 
Polymer based sorbents are organic polymer materials opposed to silica sorbents which are 
inorganic. An organic polymer sorbent eliminates problems of highly active sites found on 
silica and other oxides. The organic compound is usually a polymerization of styrene or 
methyl methacrylate. To make the polymer useful for SPE, it has to be crosslinked with 
another compound; typical crosslink agents are divinylbenzene and ethylene dimethacrylate. 
The pH range for polymer based packing materials is 1-14 because of short interaction time 
between sorbent and solvent [45]. 
 
The solid phase extraction is carried out by 4 steps: conditioning of the column, application of 
sample, washing of column and finally elution of the target compounds. The condition step is 
performed to activate the column sorbent and preparing it for the sample. If the sorbent is not 
conditioned before sample application, the functional groups will be compressed on the 
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surface and the active surface area will be very little. This is however more relevant for silica 
based columns than for the polymer based columns. Thus, the goal of conditioning is to 
increase the surface area. Thereafter, washing of the column is performed by a solution of 
similar composition as the sample. Washing of the column is typically done to get rid of the 
conditioning solvents. When the sample is applied to the column, the target compounds will 
interact with the packing material and become retained while other molecules and impurities 
pass through. By adding an additional wash step, components with weak interaction to the 
sorbent gets washed out. Target compounds can be eluted from the column by applying an 
elution solvent which should not be strong enough to elute pollutants. It is also of great 
importance when using silica based columns to not let the column dry between the 
conditioning, washing and sample application steps, to prevent packing material to collapse 
thus spoiling the extraction process [18, 45]. 
 
2.3.3 Derivatization  
 
To make compounds compatible with chromatographic analysis, derivatization is often 
needed. Derivatization is especially performed prior to GC, to convert water soluble and 
temperature labile compounds suited for GC analysis. By derivatizing compounds certain 
properties will increase: 
 
- volatility 
- detectability 
- stability 
 
By optimizing the derivatization method to increase these properties, the peak shape, intensity 
and resolution will be better.  
 
There are common types of derivatization prior to GC-analysis: 
 
- silylation 
- alkylation 
- acylation 
 
Silylation is the most commonly used derivatization method in GC, allowing a wide variety of 
compounds to be silylated and a large number of reagents are available. The derivatization 
method used in this thesis is silylation. The silyl derivatives are more volatile and more 
thermally stable than the original compounds. Trimethylsilyl (TMS) groups will replace 
active hydrogens on the compounds treated with the derivatization reagent. Trace alcohol will 
also react with the derivatization reagent leading to insufficient amounts of derivatization 
reagent to fully derivatize the target compounds. This fact makes it crucial for the end result 
to dry the sample and solvent adequately before derivatization. The reagents are sensitive to 
moisture and because of its derivatization mechanism only aprotic organic solvents can be 
used. The ranking of functional groups after silyl accepting properties are: alcohols > phenols 
> carboxylic acids > amines > amides [18, 43, 47].  
 
There are several silylating reagents, including N-trimethylsilylimidazole (TMSI/TMSIM), 
N,O-bis(trimethylsilyl) trifluoroacetamide (BSTFA), N,O-bis(trimethylsilyl) acetamide 
(BSA), trimethylchlorosilane (TMCS) and hexamethyldisilazane (HMDS). The reagents are 
ranked in that order respectively with regard to their silyl donor properties [18, 43]. BSTFA and 
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BSTFA+TMCS are the preferred reagents for trimethylsilylation of alcohols, alkaloids, 
amines, biogenic amines, carboxylic acids, phenols, and steroids. The use of BSTFA and 
BSTFA+TMCS as the most common derivatization reagents of phenolic acids prior to GCMS 
analysis seem to correspond to literature [19, 24, 25, 41, 48, 49].  TMCS is typically mixed with other 
silylating reagents to increase their reactivity and work as a catalyst. TMCS is rarely used 
alone in analytical applications [50, 51]. 
 
The mechanism of BSTFA (and TMCS) as silylating reagent, where an active hydrogen is 
replaced by an alkylsilyl group - TMS, is shown in Fig. 11 [47, 51]. 
 
 
Figure 11. Silylation mechanism of reagents BSTFA and TMCS 
 
Certain chemicals, other than TMCS, can be used to enhance the derivatization result when 
added to the derivatization reaction. Examples are chemicals such as the solvents pyridine and 
acetonitrile which both have positive effects as catalysts. A catalyst is used to increase the 
reactivity of the reagent [24]. Pyridine is also used to catch HCl formed from the derivatization 
processes where chloride is part of the reagent. The free nitrogen on the pyridine molecule 
reacts with the chloride ion.  
 
2.3.4 Solid phase analytical derivatization (SPAD) 
 
SPAD is an example of the combination of two sample preparation methods in one. The target 
compounds are adsorbed to the packing material, followed by addition of derivatization 
reagent, and finally elution of the derivatized compound. By merging SPE and derivatization, 
time will be saved as both steps are time-consuming.  
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3. Materials and methods  
 
3.1 Chemicals 
 
Acetic acid, acetone, acetonitrile (AcN), ethyl acetate (EtAc), hydrochloric acid (HCl) fuming 
37 %, methanol (MeOH), sodium sulphate (anhydrous) and tert-butyl methyl ether (MTBE) 
were purchased from MERCK (Darmstadt, Germany). β-glucuronidase with 5 % sulfatase 
activity (Type HP-2 from Helix pomatia), pyridine (anhydrous) and sodium acetate 
(anhydrous) were bought from Sigma-Aldrich (Steinheim, Germany). The derivatization 
reagents N,O-bis(trimethylsilyl) trifluoroacetamide (BSTFA) and BSTFA + 
trimethylchlorosilane (TMCS) 99:1 (Sylon BFT), were obtained from Supelco (Sigma-
Aldrich). All chemicals are of HPLC purity or better.  
 
3.1.1 Solutions 
 
Abbreviations and purities for benzoic acids (BAs) are spelt out in Table 5. Stock solutions 
were prepared for all six benzoic acids in addition to HMBA which was used as an internal 
standard for the GC system. Stock solutions of single compounds GA, PCA, VA, DHMBA, 
SA, HBA and HMBA were made by dissolving BAs in 1 mL 100 % MeOH with 
concentrations ranging from 5.79 to 13.33 mg/mL. Concentrations were calculated by 
weighing both BA and solvent on an analytical balance (accuracy of ± 0.01 mg), as well as 
considering BA purity. Deuterated internal standards of GA and HBA were prepared in the 
same way, with concentrations 8.86 and 11.45 mg/mL respectively. All user and standard 
solutions were prepared from these stock solutions. Accurate concentrations for all stock 
solutions are found in Appendix 1.  
 
Table 5. Purity and distributor of the benzoic acids and the internal standards 
Chemical name  Abbreviation Common name  Purity (%)  Distributor 
3,4,5‐trihydroxybenzoic acid  GA  Gallic acid  100  Sigma 
3,4‐dihydroxybenzoic acid  PCA  Protocatechuic acid  100  Fluka 
4‐hydroxy‐3‐methoxybenzoic acid  VA  Vanillic acid  99.40  Fluka 
3,4‐dihydroxy‐5‐methoxybenzoic acid  DHMBA  ‐  99  Fluorochem 
4‐hydroxy‐3,5‐methoxybenzoic acid  SA  Syringic acid  99.25  Fluka 
4‐hydroxybenzoic acid  HBA  ‐  99  Aldrich 
4‐(hydroxymethyl)benzoic acid  HMBA  ‐  100  Aldrich 
3,4,5‐trihydroxybenzoic‐2,6‐d2 acid  d‐GA  Deuterated gallic acid  99.30  CDN Isotopes
4‐hydroxybenzoic‐2,3,5,6‐d4 acid  d‐HBA  ‐  98.80  CDN Isotopes
  
 
PBS buffer was prepared (0.1 M, pH 7.2), using BupHTM Phosphate Buffered Saline Pack 
from Pierce, containing 0.1 M sodium phosphate and 0.15 M sodium chloride. 
 
The enzyme solution was prepared by mixing 100 µL β-glucuronidase with 5 % sulphatase 
activity (H-2, Helix pomatia, 131 700 units/mL) with 2900 µL sodium acetate buffer (0.4 M, 
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pH 4.95). 
 
3.2 Standard calibration curve 
 
Standard solutions, diluted with MTBE, were prepared from the stock solutions made of all 
BA and IS, to make a standard calibration curve (Appendix 2). Ten calibration standards, 
containing a mix of six BAs, two deuterated quantitation internal standards and one GCMS 
internal standard were prepared in nine concentrations ranging from 5.29 to 1654.52 µg/L, in 
addition to a calibration blank (Table of accurate concentrations found in Appendix 3). The 
internal standard were added to all standards with constant concentration; 197.06, 183.53 and 
172.32 µg/L for HMBA, d-HBA and d-GA in that order. 
 
The standard calibration curves used throughout the analyses made in this thesis were linear 
(eq. 1 in 2.3.5). BA concentrations were found by the principle of eq. 2 in section 2.3.5: 
 
Conc. BA = (Conc. BA IS x BA area) / BA IS area     (6) 
 
Several calibration curves were prepared throughout the analysis work because fresh standard 
solutions were made every second month to obtain reliable and reproducible results. Three 
internal standards were used in the analyses, two were the deuterated substances 
corresponding to the unlabeled substances GA and HBA; d-GA and d-HBA respectively, and 
the third was HMBA. The two isotopically labeled internal standards were used as BA IS and 
labeled IS for the standard calibration curve which the BAs are quantified by. The third IS, 
HMBA, called the GCMS IS was used to keep track of the instrument stability. If the GCMS 
IS concentration changes noticeably between analyses, the instrument sensibility is changing 
and gives an indication that a new calibration curve should be made. 
 
3.3 Sampling 
 
All samples analyzed for the utilization part of this thesis has been stored at - 20ºC or - 72ºC 
at different periods of time before analysis. Samples used for method development has either 
been stored at -20ºC or collected shortly before sample preparation.  
 
3.3.1 Urine samples 
 
Urine samples were given by volunteers (n=13) at different periods of time. An important 
aspect of analyzing urine samples is that they need to be comparable. To be able to compare 
BA concentrations in different urine samples, either the total urinary volume within each 
sampling period or the creatinine level was measured.  
 
The urine sampling can be divided into three categories:  
 
- Method development 
Spot urine from healthy volunteers (n=5) was used as matrix for development and 
evaluation of the best sample preparation method. Urine used from method 
development was mainly collected shortly before preparation. For method 
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development considering deconjugation samples stored at – 20 ºC was utilized 
because of known levels of creatinine. 
 
- Oral administration of MEDOX® 
For samples that were to be analyzed after oral administration of Medox® capsules, 
two kinds of sampling were employed: 
 
1) Spot urine sampling 
Ten healthy volunteers, ranging from 24 to 60 years of age, were orally administered 6 
capsules of Medox®. Before and two hours after ingestion of the capsules, spot urine 
samples were collected. The volunteers did not follow any diet restrictions. The urine 
samples from this experiment are from 2007 and have been stored at -20 ºC. 
 
2) 6 hour sampling  
Two healthy female volunteers were orally administered 8 Medox® capsules. Urine 
were sampled before and 1, 2, 3 and 6 hours after administration. Total urinary volume 
was measured for each time interval, as well as creatinine levels. No diet restrictions 
were followed by the volunteers. All collected urine samples were stored at -20 ºC. 
 
- Oral administration of delphinidin-3-O-β-glucopyranoside 
One healthy male volunteer was orally administered 500 mg delphinidin-3-O-β-
glucopyranoisde powder, swallowed with water. One urine sample was collected 
before ingestion of the delphinidin powder. Urine samples were also collected at each 
of the following 8 hours after administration. The volunteer followed a low 
anthocyanin diet for 48 hours prior to the administration and during the sampling 
period.  All samples were acidified (1 mL 6 M HCl to 25 mL urine), aliquoted and 
stored at -72 ºC. The samples from this delphinidin experiment have been stored since 
2007.  
 
3.3.2 Plasma samples 
 
Plasma (EDTA) samples were collected from healthy volunteers (n=4) in a similar manner as 
the urine samples. All blood samples were collected in two 10 ml EDTA vials, and 15 
minutes after collection they were centrifuged for 10 minutes at 2000 g and 4 ºC to separate 
the plasma from the remaining blood cells. Plasma from both vials was mixed to a 
homogenous sample.  
 
The sampling can be divided into the same three categories as the urine samples were: 
 
- Method development 
Plasma samples used for method development had been stored at -20 ºC. 
 
- Oral administration of MEDOX® 
For plasma samples, one kind of sampling considering oral administration of Medox® 
was applied.  Blood was collected identically to the 6 hour sampling type for urine, 
with the same two female volunteers administered 8 Medox® capsules. Samples were 
drawn before ingestion and then 1, 2, 3 and 6 hours following administration. All 
plasma samples were stored at - 20ºC. 
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- Oral administration of delphinidin-3-O-β-glucopyranoside 
The same healthy male volunteer as for urine sampling was orally administered 500 
mg delphinidin-3-O-β-glucopyranoside powder swallowed with water. A blood 
sample was drawn before the ingestion of delphinidin. Subsequent blood samples were 
collected after time intervals: 15, 30, 45, 60 and 90 minutes, and 2, 3, 4, 5, 6, 7 and 8 
hours. Plasma was acidified (40 µL 6 M HCl to 1000 µL plasma) and stored as 1 mL 
aliquots at – 72 ºC. These samples have been stored since 2007. 
 
3.4 Sample pretreatment 
 
Pretreatment of samples before preparation step included pH adjustments and enzymatic 
reactions. Both urine and plasma samples were adjusted to pH 2 by addition of 1 M HCl 
before extraction by LLE, SPE and SPAD. 
 
3.4.1 Deconjugation 
 
Some samples were deconjugated before sample preparation; this step was performed before 
acidification of samples because of optimal enzyme reaction at pH levels 4.5 – 5.  
 
Deconjugation of a sample involved adding 300 µL enzyme solution to 500 µL urine or 
plasma. The composition of the enzymatic mixture was 10 µL enzyme + 290 µL sodium 
acetate buffer (see 3.1.1). The mix was incubated for 2 hours at 37 ºC.  
 
3.5 Sample preparation 
 
All frozen samples were thawed in the refrigerator and subsequently went through a 
pretreatment step before sample preparation. The sample preparation consists of an extraction 
method and derivatization. Between the extraction and derivatization step, the sample was 
concentrated by evaporation either by nitrogen flow or vacuum centrifugation (except for in 
SPAD where the two preparation steps are combined).  
 
All three extraction methods (LLE, SPE and SPAD) were compared with the consideration of 
recovery values, peak resolution and execution.  
 
3.5.1 Derivatization 
 
BA sample extracts and standards were derivatized by the final optimized method as follows:  
 
Sample extracts or standards were derivatized in a mix of 25 % AcN, 10 % BSTFA and 65 % 
MTBE, by heating at 60 ºC for one hour.  
 
The optimized method described above was achieved by variation of the following 
parameters:  
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- Solvent 
MTBE, ethyl acetate and cyclohexane were tested as solvents in the derivatization 
method. 
 
- Derivatization vial 
Polypropylene (PP) vials and glass vials were compared to see if there was a 
difference in the result. 
 
- Derivatization reagent 
Two different derivatization reagents were tested: BSTFA and BSTFA+TMCS (99:1). 
 
- Derivatization method 
Two different setups for the derivatization performance were applied. 
 
- Derivatization catalyst 
The solvents pyridine and acetonitrile were added to the process in various 
concentrations to compare the improving effects on the derivatization (Table 6). 
 
Table 6. Different concentrations of AcN and pyridine tested for                 
improvement of derivatization efficiency 
Organic  Concentrations (%)             
solvents  1  5  10  20  25  30  50 
Acetonitrile    x  x  x  x  x  x 
Pyridine  x  x  x  x       
 
 
3.5.2 LLE 
 
Acidified urine and plasma, as well as enzyme treated and acidified urine and plasma, were 
extracted by the optimized LLE method as follows:  
 
Liquid-liquid extraction (Fig. 12) was carried out in the same matter throughout the project, 
except for change of solvent.  
 
 
Figure 12. Illustration of the liquid-liquid extraction method 
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The following extraction solvents were compared:  
 
- EtAc 
- MTBE 
- Diethyl ether 
- MTBE with 25 % AcN 
- MTBE with 20 % MeOH 
 
3.5.3 SPE 
 
Acidified urine and plasma, as well as enzyme treated and acidified urine and plasma, were 
extracted by the optimized SPE method as follows:  
 
The SPE method (Fig. 13) was performed as illustrated, with change in elution solvent. 
 
 
 
Figure 13. Illustration of the solid-phase extraction method 
   
The variables in the SPE method include: 
 
- Column packing material (RP column): 
 
1) Silica based RP column (Discovery DSC-18, Supelco. 1 mL/100mg. Polymerically 
bonded, octadecyl (18 %C), endcapped), and: 
 
2) Polymeric RP column (Strata-X 8B-S100-TAK, Phenomenex. 1mL/30mg Surface 
modified styrene divinylbenzene polymeric surface). 
 
- Elution solvents: 
Three solvents were used for elution: EtAc, MeOH and 90 % acetone. 
 
3.5.4 SPAD  
 
SPAD was examined as a method combining the two sample preparation steps; extraction and 
derivatization. Acidified urine and plasma samples were extracted using this method. The 
SPAD method (Fig. 14) is almost identical to the SPE method from the last section (3.5.3) 
except for the derivatization step which has been added after the washing step.  
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Figure 14. Illustration of the solid-phase analytical derivatization method 
 
Two different column types where applied when performing SPAD: 
 
- Anionic exchange column (Oasis Max, Waters) 
- Reversed phase (RP) column (Discovery DSC-18, Supelco) 
 
3.6 Gas chromatography mass spectrometry (GCMS) analysis 
 
The instrument combination used for sample analysis in this thesis was gas chromatography 
coupled with a mass spectrometry using electron ionization: GC-EI-MS. The analytical 
equipment consisted of a Shimadzu GCMS-QP2010 (QP – quadrupole) and an AOC-5000 
autosampler (Bergman, Norway), controlled by Shimadzu GCMS Labsolutions (Version 2.50 
SU1). Samples and standards were injected in splitless mode with a sampling time of 1 min. 
Helium was used as carrier gas and the initial column used during most of the project was 
Factor Four capillary column, 50 m x 0.25 mm with 0.25 µm film thickness (Varian, 
Netherlands). The Factor Four column was replaced towards the end of the utilization 
analyses to CP-SIL 8 CB-MS, 50 m x 0.25 mm with 0.25 µm film thickness (Varian, 
Netherlands). A more complete list of instrumental settings can be found in Appendix 4 
(Instrumental settings GCMS). 
 
A GC method is composed by time and temperature adjustments. The ramp, meaning how 
much increase in degrees Celsius will occur per minute, is adjusted in the GC method. By 
elongating or shortening the temperature interval, a compounds retention time will change. 
One GC method was chosen, and only changed slightly during the analysis work due to 
column cutting. The column was replaced towards the end of the project; a new GC method 
compatible with BA separation and the new column was then made.  
 
To detect the compounds separated by GC, a mass spectrometer is coupled with it. The initial 
analyses of single compounds of GA, PCA, VA, DHMBA, SA, HBA, HMBA, d-GA and d-
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HBA was made in SCAN mode. The range was set to 70 – 500 m/z. After determination of 
identifier (qualifier) and quantifier ions, SIM mode was proceeded with for all analyses. 
 
3.7 Limit of detection (LOD) / limit of quantification (LOQ) 
 
The limit of detection (LOD) is the quantity or concentration of the smallest amount 
considered detectable for an analytical method. The limit of quantification (LOQ) is the 
smallest quantity or concentration considered reliable enough to measure the quantity.  
 
The LOD (eq. 7 & 8) and LOQ (eq. 9 & 10) values are calculated by means of the signal-to-
noise (S/N) ratio and the knowledge of the injected concentration. In GCMS, the LOD value 
is defined to be 3 times higher than the background noise (S/N ≥ 3), and LOQ 10 times higher 
(S/N ≥ 10). Since there is more uncertainty and difficulty in the quantification of a compound 
than the detection of it, the S/N value needs to be higher for LOQ determination.  
 
Determination of LOD:  
 
f = S/N / 3           (7) 
 
LOD = injected concentration / f        (8) 
 
Determination of LOQ: 
 
f = S/N / 10           (9) 
 
LOQ = injected concentration / f        (10) 
 
The post analysis program for the GC can give an estimation of the S/N values for all 
compounds, or the S/N value can be determined by observation and comparison of the height 
of the peak and the surrounding noise.  
 
To determine LOD and LOQ, the standard solution of lowest concentration (std.  2) for the 
standard calibration curve was diluted to find S/N values corresponding to the LOD and LOQ 
limits. 
 
The standard deviation (SD) for each compound’s LOD and LOQ values was calculated (eq. 
11). Where N is the number of values of which the mean and SD is calculated from, and 
represents the mean value.  
 
       (11) 
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3.8 Recovery 
 
Recovery is used to indicate the yield of an analyte in a preconcentration or extraction stage in 
an analytical method [52]. Recovery (eq. 12) is determined by dividing the obtained 
concentration by analysis with the concentration which the sample was spiked with before 
undergoing the process leading up to the analysis. In this case the sample goes through an 
extraction and derivatization step. To get the recovery percentage, the result is multiplied with 
100. SD (eq. 11) has also been calculated for all recovery values. 
  (12) 
 
3.9 Utilization 
 
BA concentrations in urine samples have to be corrected with regard to either creatinine levels 
or total urinary volume to be comparable (eq. 13 & eq. 14). 
 
Correction of concentration taking creatinine levels into account: 
   (13) 
Correction due to total urinary volume: 
 
Conc. compound (µg/L) x total volume (L) = µg compound    (14) 
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4. Results and discussion 
 
4.1 Gas chromatography mass spectrometry (GCMS) 
 
4.1.1 Mass spectrometry 
 
Initially, TMS derivatives of single BAs were injected and their mass spectra recorded in full 
scan mode (m/z 70 – 500). The full scan spectra were used for selection of ions for 
quantitative SIM analyses of a mix of all target compounds.  
 
Identifier and quantifier ions were chosen based on the evaluation of the mass spectras for 
each individual compound (Fig. 15). Some mass spectra contain a limited number of 
prominent ions (Fig. 15 upper), which ease the selection of quantifier ion and identifier ion, 
whereas other spectra have several alternatives (Fig. 15 lower). The mass spectrum for gallic 
acid is easier to determine ions for than for instance syringic acid, both shown in the example. 
When a compounds mass spectrum contains multiple ion alternatives, the most prominent and 
unique ions are generally chosen.  
 
 
 
 
Figure 15. Mass spectra of GA (upper) and SA (lower) with arrows showing selected   
        identifier and quantifier ions. 
 
Mass spectra for the remaining compounds not represented in Fig. 15 are found in Appendix 
5. 
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Selected quantifier and identifier ions are presented in Table 7. 
 
Table 7. Quantifier and identifier ions for each individual compound analyzed in the  
     thesis 
   Ions    
Compound  Quantifier  Identifier 
GA  281  458 
PCA  193  370 
VA  297  312 
DHMBA  223  400 
SA  327  342 
HBA  267  282 
HMBA  281  296 
d‐GA  283  460 
d‐HBA  271  286 
 
The ions selected as quantifier and identifier ions for all BAs correspond to the general 
fragmentation patterns found in literature [19, 24, 25, 41]. The three BAs with two or more TMS 
groups present in adjacent positions on the benzene ring, GA, PCA and DHMBA, all have a 
prominent peak at [M-177]+ which is a common fragment for those components. This is also 
the case for the IS d-GA. The remaining BAs, containing only TMS groups in non adjacent 
positions, all have quantifier ions based on the [M-15]+ fragment. As can be observed in the 
SA mass spectrum (Fig. 15), other common ion fragments such as [M-30]+, [M-59]+ and [M-
89]+ are also found. The [M-15]+ fragment, however, has highest intensity and one of the most 
unique masses found compared to the other BAs chromatograms, and is therefore chosen, as 
is the case for the other BAs too.  
 
All the 17 selected ions were used for quantitative analysis in SIM mode. Since the detector 
sensitivity decreases with an increasing number of simultaneously acquired SIM ions, the 
number of ions in one acquisition window is limited to 10. Therefore, the selected ions were 
acquired in two chromatographic time windows (Fig. 16). By specifying which masses the 
detector will recognize in SIM mode, unwanted peaks with similar retention times will be 
excluded and thereby improves the background noise. 
 
 
Figure 16. Chromatogram showing two acquisition (time) windows 
 
The acquisition windows end and start where there is sufficient time between two peaks. The 
ions for the first 5 compounds are programmed to be acquired in the first window, and the 
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ions of the remaining 4 compounds are registered in the next window. The order in which the 
compounds appear in the chromatogram is presented in section 4.1.2. 
 
4.1.2 Gas chromatography 
 
The retention time of each compound varies depending on which GC method is used, and 
changes if the column is shortened (by end-capping) or if a new column of different length is 
installed. However, even if the retention time changes due to various causes, the sequence of 
the compounds in the chromatogram will not change.  
 
The GC method used, with small modifications due to column-cutting or change of column, is 
shown in Table 8:  
 
Table 8. BA SIM method 1 
Ramp  Temperature  Holdtime 
ºC/min  ºC  min 
‐  50  1 
25  160  0 
3  215  0 
15  300  5 
 
Even though the analytes can be separated in a GCMS analysis, the goal is to achieve 
optimized results. To achieve this, several factors can be adjusted to improve the separation of 
the compounds. A good separation means having a high efficiency and resolution value. The 
separation can be altered either by making changes in the GCMS methods or making changes 
in the sample preparation before analysis.  
 
Initially, the temperature programs were changed to find out if the separation improved (Fig. 
17). The method which resulted in shortest retention times was chosen, presented by the upper 
chromatogram in the figure.  
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Figure 17. Difference in chromatograms caused by change in GC temperature program 
 
The peak separation of the three methods compared with regards to changes in the 
temperature program is similar, and the method chosen for further analysis results in higher 
sample throughput. The intensity of the peaks in the upper chromatogram in Fig. 17 is also 
higher as compared to the two other methods due to narrower peaks. The time period 
separating the peaks in the middle and lower chromatogram are longer, however, since the 
resolution for the first is very good that method was chosen.  
 
When the GC column was replaced towards the end of the experimental work, the retention 
times shifted and made it necessary to alter the GC method slightly. The retention times was 
pushed forward by approximately 2 minutes, making the new method slightly longer than the 
previous (Table 9). 
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Table 9. BA SIM method 2 
Ramp  Temperature  Holdtime 
ºC/min  ºC  min 
‐  50  1 
25  160  0 
2.5  215  0 
15  300  4 
 
The sequence of the compounds analyzed was determined by first analyzing each separate 
compound and thereafter a mixture of all BA and IS (Table 10).  
 
Table 10. Sequence of the compounds 
Sequence  Compound 
1  d‐HBA 
2  HBA 
3  HMBA 
4  VA 
5  PCA 
6  SA 
7  DHMBA 
8  d‐GA 
9  GA 
 
The two deuterated internal standards, d-HBA and d-GA, have very similar retention time to 
the corresponding BAs HBA and GA respectively, due to their small difference in mass. 
Therefore there will only seem as though there is one peak for d-HBA + HBA and d-GA + 
GA in the total ion current (TIC) chromatogram.   
 
4.2 Sample preparation 
 
Two sample preparation methods, LLE and SPE, have been compared with respect to 
extraction efficiency of BAs. Derivatization has also been optimized to give the best possible 
result considering derivatization efficiency and chromatographic performance. A third 
extraction method combining SPE and derivatization was also tested because it would mean a 
less time consuming sample preparation step. A poster presenting some of the results for 
method development of sample preparation techniques was enrolled to the 2010 Symposium 
of Chromatography in Sandefjord (Appendix 6).  
 
LLE was chosen as the best extraction method compared to both SPE and SPAD based on 
recovery and chromatographic peak separation. SPAD was excluded for further analyses early 
in the method development process due to poor results. LLE and SPE was explored more 
thoroughly, however LLE yielded better recovery of all BAs as well as a better 
chromatographic separation of peaks (Fig. 18). LLE is also a less labor demanding method 
taking less time to perform. Results for each sample preparation method are presented in the 
following sections.  
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Figure 18. Comparison of peak shape of three BA using LLE and two different SPE  
        columns 
 
Recovery percentage for each compound has been determined for LLE, SPE and SPAD. 
Recovery for both LLE and SPE using different extraction solvents have been acquired and 
for LLE both with and without deconjugation of samples. For SPE and SPAD recovery results 
have been determined in urine samples, whilst for LLE recovery results have been determined 
in both urine and plasma matrices being the method of choice. Recovery values for each 
extraction method are presented under their respective section and accordingly discussed and 
compared in the following recovery section (4.2.5). 
 
For the utilization part of the results, the BA concentrations in different samples needed to be 
compared. Urine samples are often of different densities and concentrations which need to be 
taken into account before comparison of the BA concentrations. To be able to compare the 
BA concentrations in urine samples before and after ingestion of MEDOX® capsules, 
creatinine levels were used as a measure. For the samples given before and after intake of 
delphinidin-3-O-β-glucopyranoside powder, total urinary volume was used for comparison.  
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Creatinine levels give an indication of how concentrated a urine sample is. Creatinine is a 
break down product of creatine phosphate in the muscles. The kidneys filter creatinine out of 
the blood and the creatinine leaves the body in the urine [53]. Depending on how much fluids a 
person has consumed, the creatinine levels will vary. Morning urine has an especially high 
value, and if a person drinks a lot which they will in the case of these types of experiments in 
this thesis, the creatinine levels will drop. 
 
With regard to the sample pretreatment, the composition of the enzyme solution is based on 
similar studies. The solution used in this thesis, is an approximation of the method used by 
Nurmi et al. 2006 [15] with 2500 U β-glucuronidase/mL urine. The sample material used in the 
experiments are 0.5 ml (= 1250 units/ 0.5 mL). The β-glucuronidase with 131700 U/mL 
equals 132 U/µL, and it is therefore used 10 µL of enzyme to every 0.5 mL sample 
deconjugated. Nurmi et al. used a sodium acetate buffer with a pH of 4.1, which is a little 
lower than the optimal pH for deconjugation of 4.5 – 5, and the buffer made for this 
experiment is therefore of a higher pH value.  
 
Also different deconjugation times have been tested to optimize the deconjugation treatment 
of the samples. There was some difference in incubating the samples at 37 ºC for 1, 2 and 3 
hours for most BAs (Fig. 19). A slight increase in recovery was obtained for allowing the 
samples to incubate for 2 hours compared to 1 hour for HBA, VA and SA. For the remaining 
3 BAs, PCA, DHMBA and GA, there was a vast difference. No significant improvement was 
however found by increasing the incubation with another hour from 2 to 3 hours of 
incubation, only decrease for most compounds if anything. 2 hours incubation time was based 
on these results considered the best choice for deconjugation.  
 
 
Figur 19. Effect of different incubation times for deconjugation 
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The effect is measured by the difference in concentration found after the three time spans. In 
Fig. 19, the effect given by 2 hours of incubation is set as 100 % being the overall best 
incubation time. 
 
4.2.1 Derivatization 
 
The optimized derivatization method as presented in the materials & methods section 3.7.1 is 
as follows: 100 µL BSTFA, 250 µL AcN and 650 µL MTBE added to the evaporated sample 
to a total of 1 mL.  
  
Derivatization of the analyzed benzoic acids was necessary to be able to analyze them by 
GCMS. The derivatization increases the volatility of the BAs and their thermal stability, by 
converting protonic functional groups into thermally stable nonpolar groups. The 
derivatization was optimized by altering a number of factors and comparing the 
chromatographic result of each of the alternatives. The following aspects were examined: 
solvents, derivatization reagent, derivatization catalyst, derivatization method and vials for 
derivatization.  
 
4.2.1.1 Derivatization solvents 
 
MTBE was chosen as the solvent giving best results for derivatization.  
 
A mixture of the six benzoic acids and the GC IS, HMBA, was analyzed by GCMS and the 
solvent presenting the best chromatographic result was chosen. By comparing the three 
different solvents MTBE, ethyl acetate and cyclohexane, MTBE gives the best result. It is 
important to have a method where the resolution is the best possible, with good peak 
separation, peak shape and as little background noise achievable.  
 
By comparing the resulting chromatograms (Fig. 20) for each derivatization solvent, it is 
clearly MTBE that is the best choice to pursue for further derivatizations. There is less 
background noise than for the other two solvents, and the peak shape is sharper for all BAs 
with perhaps an exception for GA which has some tailing. The peaks in the MTBE 
chromatogram show in general little or no tailing, with an exception for GA while 
cyclohexane gives tailing both in front and the back of the BA peaks. Ethyl acetate also give 
tailing in addition to as an excess of background noise and other peaks with the same 
intensities as the BA peaks.    
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Figure 20. Chromatographic result of different derivatization solvents 
 
4.2.1.2 Derivatization vials  
 
Polypropylene (PP) vials were used for derivatization initially but the chromatogram showed 
a lot of noise giving reason to believe the vials could be of importance to the result. The PP 
vials are supposed to be inert but somewhere in the derivatization process these vials interfere 
with the end result. Glass vials were tested to compare the difference in chromatographic 
appearance. Glass vials gave a visibly better result than PP vials (Fig. 21). 
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Figure 21. The use of PP vials vs. glass vials 
 
After testing the significance of vial application, it became clear that PP vials could be used 
for the initial steps of sample preparation, including the extraction, without interfering with 
the results. Switching to glass vials before evaporation and derivatization of the sample 
material was however a necessary effort to improve the result. 
 
4.2.1.3 Derivatization reagents 
 
Two derivatization reagents (DR) were evaluated: BSTFA and BSTFA+TMCS. The selected 
DR for further analyses was BSTFA. 
 
BSTFA+TMCS was tested because TMCS is often found to be a catalyst to increase TMS 
donor potential. In this case, however, BSTFA alone gave a better result for the intensity of 
the BA peaks (Fig. 22).  
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Figure 22. Difference in peak area by using BSTFA vs. BSTFA+TMCS as DR 
 
In the figure above (Fig. 22), BSTFA is set as 100 % as it gave the best results, for illustration 
of the difference between the two reagents.  
 
4.2.1.4 Derivatization method 
 
Two setups for the derivatization methods have been applied and compared to choose the best 
way to perform the derivatization step of sample preparation (Fig. 23). 
 
 
Figure 23. Two derivatization methods 
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Method 1 (Fig. 23 upper) show a derivatization method where evaporation of sample material 
is done before derivatization, whereas method 2 (Fig. 23 lower) apply evaporation both before 
and after the heat treatment.  
 
Method 1 has been utilized throughout the project, this is because the methods do not differ 
much in result (Fig. 24) and it is less time consuming. The intensity of the peaks given by 
using derivatization method 1 is slightly higher than those of method 2. 
 
 
Figure 24. Difference in derivatization methods presented by their chromatograms 
 
The chromatograms shown in Fig. 24 are the result of derivatization before any derivatization 
catalysts was added to the method, which could explain why there is some tailing.  
 
In the final procedure, an additional drying step was added prior to derivatization to avoid 
excess moisture. Anhydrous sodium sulphate was added to the sample extract after 
evaporation. The rest of the derivatization process was carried out in the same matter. 
 
4.2.1.5 Derivatization catalysts 
 
Acetonitrile (AcN) or pyridine was added separately in several concentrations to improve the 
outcome of the derivatization (Fig. 25). AcN was chosen as the best catalyst to the 
derivatization reaction of the two, and 25 % was proven to be the most effective 
concentration. The different concentrations used for derivatization with pyridine were: 1, 5, 
10 and 20 %. Concentrations compared for acetonitrile was initially 5, 10, 20, 25, 30 and 50 
%, of which 20 – 30 % AcN gave best results, leading to further analysis of 20, 25 and 30 % 
AcN to find the best concentration for derivatization.  
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Figure 25. Effect on peak intensity using different concentrations of pyridine and AcN  
                  for derivatization 
 
10 % pyridine for derivatization gave the best result for pyridine added to the derivatization 
process (Fig. 26) and 25 % AcN gave the best result of the acetonitrile concentrations tested 
(Fig. 27). The peak intensity and peak area are both higher for 25 % AcN and it was therefore 
chosen as the best derivatization catalyst.  
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Figure 26. Difference in derivatization result by the addition of various amounts of  
                  pyridine 
 
The y-axis of the figure above (Fig. 26) represents the peak area (%) compared to the best 
acetonitrile concentration which is set to 100 %. From the figure it is clear to see that 10 % 
pyridine gives the best result, however compared to AcN the effect is visibly lower.  
 
 
Figure 27. Peak area effect caused by different amounts of AcN for derivatization 
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The effect seen in Fig. 27 above show that 25 % acetonitrile is evidently the best 
derivatization catalyst.  
 
4.2.2 Liquid-liquid extraction (LLE) 
 
LLE was chosen as the best sample extraction method compared to SPE (4.2.3) and SPAD 
(4.2.4). The best extraction solvent for LLE was found to be ethyl acetate (EtAc) based on 
extraction efficiency and reproducibility.  
 
The other solvents evaluated were: MTBE and diethyl ether. Chromatograms for the samples 
extracted with the different solvents are presented in Fig. 28.  
 
 
 
 
Figure 28. Effect of LLE extraction solvents: Ethyl acetate, MTBE and diethyl ether 
  
There is very little difference in the chromatographic appearance comparing samples 
extracted with EtAc, MTBE and diethyl ether. The BA peak intensities are highest for EtAc, 
then slightly lower for MTBE in comparison and accordingly slightly lower for diethyl ether 
compared to MTBE. 
 
Addition of a polar solvent to the extraction solvent was made in an attempt to modify the 
phases for a possible improvement of extraction yield. MTBE w/ 25 % AcN and MTBE w/ 20 
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% MeOH were compared with the other solvents. However, both the added solvents, AcN and 
MeOH, modified the water phase instead and there was a significant decrease in recovery and 
lack of reproducibility for the obtained results.  
 
All recovery experiments considering extracting solvents were performed on urine samples 
which were not deconjugated. The recovery results for the target compounds are presented in 
Table 11.  
 
Table 11. Recovery results for the six target BAs in urine applying different extraction  
                 solvents for LLE   
      Recovery (%)±SD     
BA 
Ethyl acetate 
(n=5)  MTBE (n=5) 
Diethyl ether 
(n=4) 
MTBE w/ 20 % 
MeOH (n=3) 
HBA  89 ± 5  88 ± 3  85 ± 4  67 ± 13 
VA  100 ± 6  97 ± 6  92 ± 4  25 ± 35 
PCA  95 ± 4  91 ± 2  82 ± 2  20 ± 48 
SA  105 ± 6  100 ± 3  91 ± 3  20 ± 33 
DHMBA  94 ± 6  88 ± 2  72 ± 2  19 ± 34 
GA  121 ± 4  114 ± 1  113 ± 3  65 ± 26 
 
Based on the recovery results, EtAc was chosen as the best extraction solvent and used to 
determine the recovery for BAs in both urine and plasma, using the optimized LLE extraction 
method. Recovery yield for both matrixes have also been obtained for both deconjugated 
samples and samples not treated with enzyme. Any presence of the target BAs in urine and 
plasma samples before spiking is subtracted before calculation of recovery. 
 
- Recovery results for BA in urine: 
 
5 parallels (n=5) of spiked urine samples extracted with LLE by EtAc was analyzed 
with regard to each BA. The recovery results presented are the calculated average 
(mean), and the standard deviation is also given for each value. Recovery values for 
samples both undergoing deconjugation and for samples not treated with enzyme is 
presented in Table 12.  
 
Table 12. Recovery (%) for BA in urine, n= 5 
   Recovery (%) ± SD 
BA  Urine   Urine (deconjugated) 
HBA  89 ± 5  96 ± 12 
VA  100 ± 6  107 ± 30 
PCA  95 ± 4  79 ± 6 
SA  105 ± 6  73 ± 19 
DHMBA  94 ± 6  62 ± 3 
GA  121 ± 4  121 ± 4 
 
HBA and VA have both elevated recovery values after deconjugation compared to in 
the samples which are not enzyme treated. These BAs also have higher standard 
deviation values as compared to the not enzymatically treated urine which is the case 
for most BAs after deconjugation here. The elevated recovery values in addition to 
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recovery values over 100 % could most likely be explained by interfering peaks which 
cannot be separated from the BA peaks. Some BAs, PCA, SA and DHMBA have 
lower recovery % after deconjugation. The addition of a deconjugation step means an 
extra sample preparation step which increases the possibility of BA loss before 
analysis.  
 
- Recovery results for BA in plasma: 
 
3 parallels (n=3) of spiked plasma samples was analyzed for all target BAs, and 
recovery results for each compound is presented as the calculated mean. The SD is 
also specified for each recovery value. Recovery for the six BAs is presented in Table 
13 with recovery results for both deconjugated samples and samples which have not 
been given any enzyme treatment. 
 
Table 13. Recovery (%) for BA in plasma, n=3 
   Recovery (%)  ± SD 
BA  Plasma 
Plasma 
(deconjugated) 
HBA  57 ± 3  60 ± 1 
VA  105 ± 5  116 ± 3 
PCA  63 ± 3  55 ± 3 
SA  139 ± 7  158 ± 3 
DHMBA  64 ± 6  37 ± 2 
GA  80 ± 3  81 ± 2 
 
In plasma there is a little higher recovery % for the deconjugated samples on the 
whole compared to not enzymatically treated samples, except for PCA and DHMBA 
which are lower. This could indicate some loss of these compounds during that sample 
pretreatment step, however there could also be loss of these in a later preparation step. 
High recovery values, over 100 %, could be the result of interfering peaks. In the case 
of the plasma samples, SA and VA are the two BAs with highest recovery results 
which are both over 100 %.  
 
4.2.3 Solid phase extraction (SPE) 
 
To achieve the best possible recovery results for an extraction method, an alternative method 
to LLE was examined: Solid phase extraction (SPE). Comparison of the two methods 
considering recovery results made LLE the best method, and SPE was therefore not used for 
further sample preparation.  
 
The components of SPE tested for improvement of the outcome were: column packing 
material and elution solvents. The results were compared based on recovery results and 
chromatographic peak appearance.  
 
Two SPE packing materials were tested; silica based column material vs. polymeric based 
(Table 14). 
Chromatography of metabolites in plasma and urine  
following oral administration of anthocyanin rich capsules 
 
49 
Master thesis: Biological chemistry 
 
Table 14. Difference in peak area using silica- and polymer based column sorbents 
         Peak area          
SPE sorbent  HBA  VA  PCA  SA  DHMBA  GA 
Silica  167544  1167828  14608  2174580  251384  4764 
Polymer  2830608  1967784  1683328  1610080  2986324  198132 
 
Based on the areas from Table 14, polymer based packing material for the RP column give 
best results. SA is the only compound with higher peak area using the silica based packing 
material than the polymer based packing material. However, polymeric is a better choice on 
the whole. Another advantage using polymer based RP columns is that it has higher pH range 
than the silica based, and the packing material does not collapse if the column dries up 
between SPE steps.  
 
When the optimal column sorbent (packing material) was determined, different elution 
solvents was tested to find the solvent giving the best results. 90 % acetone was chosen as the 
best elution solvent based on recovery results. MeOH and EtAc were also tested as extraction 
solvents. EtAc was eliminated early in the process due to poor results (Fig. 29). 
 
 
Figure 29. Peak shape and separation using different elution solvents for SPE 
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Ethyl acetate as elution solvents gave poor chromatographic results regarding peak resolution. 
90 % acetone and MeOH, for which the chromatographic result and peak intensities was very 
similar, was proceeded with further to obtain recovery results (Table 15). 
 
Table 15. Recovery (%) results for SPE using different extraction solvents  
   Recovery %   ± SD 
BA 
90 % Acetone 
(n=5)  MeOH (n=5) 
HBA  36 ± 4  34 ± 6 
VA  74 ± 5  73 ± 13 
PCA  79 ± 7  73 ± 14 
SA  125 ± 17  120 ± 7 
DHMBA  104 ± 8  101 ± 5 
GA  43 ± 2  53 ± 14 
 
4.2.4 Solid phase analytical derivatization (SPAD) 
 
Because sample preparation before GCMS analysis is quite time consuming, solid phase 
analytical derivatization was examined as an alternative method. SPAD involves the 
combination of SPE and derivatization in one method.  Because SPAD gave very unstable and 
poor results for extraction, it was excluded for further analysis early in the method 
development procedure.  
 
Two column types were tested initially to find the column giving best results for extracting 
the compounds (Fig. 30).  
 
 
Figure 30. Anionic exchange column vs. reversed phase column for SPAD 
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Because the reversed phase column gave best results of the two column types, it was used for 
both SPAD and SPE during the rest of the method development process. The SPAD testing 
different columns was performed by applying BAs in 0.05 M HCl to the RP column and BAs 
in PBS buffer to the anionic exchange column. Recovery results for SPAD were acquired 
using RP column (Table 16).  
 
Table 16. Recovery (%) results for SPAD 
  
BA  Recovery (%) ± SD 
HBA  45 ± 33 
VA  n.a. 
PCA  1 ± 1 
SA  n.a. 
DHMBA  n.a. 
GA  n.a. 
  
n.a.: not available due to major interferences or loss of internal standards during sample 
preparation.  
 
As the recovery values from the table above (Table 16) indicates, SPAD is a very unstable 
sample preparation method for BAs with very poor reproducibility. When internal standards 
are poorly derivatized or extracted they will spoil the credibility of the analysis results. If the 
sample material does not contain the internal standards or very little of these due to a bad 
sample preparation method but contain some of the target compounds, it will seem as though 
these exist in very high amounts in the sample. The peaks for the internal standards are very 
low and barely above the detection limit. Because the internal standards are very poorly 
recovered all the other recovery values will not be credible since they cannot be properly 
calculated. 
 
Considering the unstable results and poor reproducibility of SPAD as sample preparation, it 
was excluded for the rest of the method development as LLE and SPE proved to be better and 
more stable sample preparation methods.  
 
In SPAD more than in the SPE process, drying of the column is very important because the 
derivatization reagent is applied directly to the column. The derivatization reagent used in 
silylation replaces the protonic groups with a trimethylsilyl (TMS) group. Any presence of 
water or solvents like alcohols might cause an incomplete derivatization. Also in SPAD the 
column cannot be allowed to dry between the first three steps of the extraction process for 
silica based columns. Because the columns were allowed to dry a long time and sufficient 
amounts of the derivatization reagent was added to the column before heat treatment, it leads 
to the assumption that BAs are not suitable for SPAD.  
 
4.2.5 Recovery 
 
By comparing the recovery results and the reproducibility (the standard deviation is a measure 
of this) for the three sample extraction methods, LLE, SPE and SPAD (Table 17), it is safe to 
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say that LLE is the best sample extraction method for the six target compounds: HBA, VA, 
PCA, SA, DHMBA and GA.  
 
Table 17. Recovery (%) results for LLE, SPE and SPAD in urine for the best method 
     
Recovery 
(%) ± SD    
BA  LLE (n=5)  SPE (n=5)  SPAD (n=3) 
HBA  89 ± 5  36 ± 4  45 ± 33 
VA  100 ± 5  74 ± 5  n.a. 
PCA  95 ± 4  79 ± 7  1 ± 1 
SA  105 ± 6  125 ± 17  n.a. 
DHMBA  94 ± 6  104 ± 8  n.a. 
GA  121 ± 4  43 ± 2  n.a. 
n.a.: see Table 16. 
 
SPAD was excluded for further method development quite early in the process. LLE and SPE 
was continued with to determine which sample extraction method to pursue further. SPE with 
polymer based column proved to give better recovery results than SPE silica based column. 
LLE was in the end chosen to be the best overall sample extraction method for all the BAs 
considering recovery and chromatographic results in peak separation and peak intensities. In 
the figure below (Fig. 31) recovery differences in LLE, SPE-RP (silica) and SPE-RP 
(polymer) is displayed together with the standard deviation.  
 
 
Figure 31. Difference in BA recovery (%) using LLE, SPE-RP (silica) and SPE-RP  
                  (polymer), n=3 
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4.3 Limits of detection (LOD) and limits of quantification (LOQ) 
 
Standard 2 for the standard calibration curve was diluted 1:2, 1:5 and 1:10 in MTBE to 
determine LOD and LOQ by evaluating the S/N values. The signal stands out from the noise 
surrounding it (Fig. 32). 
 
 
Figure 32. Illustration of signal and noise 
 
The S/N values used for LOD and LOQ determination was not calculated by the GCMS post 
analysis program but determined by observation of the signal and surrounding noise in the 
chromatogram. LOD and LOQ values for all BAs are presented in Table 18. 
 
Table 18. Limits of detection and quantification for all BA TMS derivatives 
BA 
LOD (µL), 
n=4, n=5 for SA 
LOQ  (µL), 
n=5, n=10 for PCA 
HBA  0.514 ± 0.127  1.706 ± 0.223 
VA  0.479 ± 0.106  1.548 ± 0.240 
PCA  0.531 ± 0.062  1.984 ± 0.798 
SA  1.155 ± 0.169  3.280 ± 0.296 
DHMBA  0.267 ± 0.028  1.048 ± 0.161 
GA  0.486 ± 0.027  2.676 ± 0.106 
 
LOD for HBA, VA, PCA, DHMBA and GA was determined from the 1:10 dilution of std. 2, 
where SA was determined from the 1:5 dilution. LOQ for HBA, VA, PCA and DHMBA was 
determined from the 1:5 dilution, while SA and GA were determined from the 1:2 dilution. In 
addition to determining LOQ for PCA with 1:5, the 1:2 dilution was also used. The limits of 
detection and quantification are quite low for all BAs, allowing for very small amounts of all 
compounds to be detected in the urine and plasma samples that were to be analyzed for the 
utilization part of the thesis work.  
 
4.4 Utilization 
 
To be able to discuss whether the selected BAs; GA, PCA, VA, DHMBA and SA, really 
could be metabolites of the different anthocyanins found in MEDOX, a number of volunteers 
were orally administered MEDOX® capsules. Urine and plasma samples were collected from 
the volunteers both before ingestion and for a time interval after to be able to see if there was 
an increase in the target compounds.  Delphinidin-3-O-β-glucopyranoside powder was also 
administered to one volunteer to see if there would be an increase in GA which is the 
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suggested metabolite for this anthocyanin. 
 
A MEDOX® capsule, containing 80 mg anthocyanins, was dissolved in 100 ml 0,01 M HCl  
(800 mg AC/L) and extracted with LLE and derivatized before analysis by GCMS to 
determine the BA content in the capsule itself. The result showed that there were < 0.1 ‰ 
BAs in the MEDOX® capsule compared to the AC concentration. It is likely to assume that 
the BA content in MEDOX® is not significant for the analysis results. However, the 
possibility of these BA contributing to the excreted BA levels after oral administration of 
MEDOX® cannot be excluded completely due to little knowledge of BA absorption 
efficiency.  
 
Benzoic acids are believed metabolites of anthocyanins, as well as they are used as food 
preservatives on their own. Since the volunteers administered MEDOX® were not under any 
diet restrictions, BAs could also originate from other food sources. The volunteer who 
ingested the delphinidin powder was following a low anthocyanin diet; still, anthocyanins are 
part of a vast number of dietary sources making total avoidance difficult.  
 
4.4.1 Urine samples 
 
Urine samples from all volunteers before ingestion of MEDOX® was analyzed, and the total 
concentration of the six BAs as well as the concentration of the BAs in their free form was 
found. The distribution of the compounds is presented in Fig. 33.  
 
 
Figure 33. Free and total BA in urine before administration of MEDOX® 
 
There is both free and conjugated BA in urine before ingestion of MEDOX®. The figure (Fig. 
33) is based on numbers of analyzed urine from 12 volunteers as regards to the creatinine 
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concentration in the urine samples. As the figure shows, VA and HBA are main constituents 
excreted in urine compared to the other analyzed BA, both in free and conjugated form. GA 
and DHMBA are only found in very small amounts.   
 
4.4.1.1 Oral administration of MEDOX® 
 
- Spot urine sampling: 
 
10 volunteers were administered 6 MEDOX® capsules (480 mg anthocyanins) to see whether 
there would be an increase in the suggested BA metabolites of the anthocyanins in the 
product. The change in BA concentration is presented as the difference between the 
concentration 2 hours after ingestion and the concentration before; all values have been 
corrected to creatinine levels. Positive values indicate increase in BA concentration after 
ingestion and negative values show decrease. The values in the diagrams represent µg 
BA/mmol creatinine. Change in concentration of free BA is presented in Fig. 34.  
 
 
Figure 34. Change in free BA in urine 2 hours after MEDOX® ingestion (positive value  
                  show increase), n=10 
 
HBA should not be found in the urine due to MEDOX® ingestion since pelargonidine is not 
one of the five anthocyanins found in the product. There is a decrease in BA after 2 hours for 
the sixth volunteer and also for VA and PCA for the third volunteer. In general there is an 
increase in the 5 BAs for all volunteers. The change in total amount of BA shows the same 
tendency (Fig. 35). 
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Figure 35. Change in total BA concentration in urine 2 hours after MEDOX® ingestion  
                  (positive value show increase), n=10 
 
HBA should not be found in the urine due to ingestion to MEDOX® so the presence of this 
BA is most likely due to the volunteers’ diet or metabolism of other compounds. There is 
generally an increase of all BAs 2 hours following oral administration of MEDOX®. 
Volunteer number 3 have a decrease of VA and PCA compared to the concentration at time 
zero meaning before ingestion, however the following three BAs SA, DHMBA and GA 
increase for this volunteer. For the sixth volunteer though, all BA decrease in concentration 
after 2 hours. That BAs decrease in concentration 2 hours after ingestion could mean that it 
will take longer for the compounds to be excreted in the urine, since there is an increase for 
the majority of volunteers this is probably not the case. Another reason could be that the 
volunteers have a high concentration of these compounds already in their urine due to their 
diet. Fruits and also coffee which are normal constituents to an average diet, contain ACs and 
BAs. General increase for all BA indicated that these could be metabolites from their 
corresponding anthocyanins in MEDOX®. All volunteers were responsible for labeling their 
own samples, which lead to another possibility for the decrease of BAs for volunteer 6 after 
ingestion of MEDOX®. The creatinine levels for this volunteer were also higher after the 2 
hours following ingestion than before, which is generally not the case. If the samples were 
mixed and the before and 2 hours after test is in reality the opposite, there was also an 
increase in all BAs for this volunteer.  
 
- 6 hour sampling: 
 
2 healthy female volunteers were administered 8 MEDOX® capsules (640 mg anthocyanins) 
and the BA concentration was analyzed the following 6 hours to observe a possible increase 
in BAs in addition to getting an idea of how fast the compounds are excreted into urine. Total 
amount of BA excreted in the urine during the 6 hour period following administration was 
2778 µg for volunteer 1, where HBA, VA and PCA together makes up for 92 % of the total 
BA concentration. Total excreted BA in urine for volunteer 2 was 1939 µg where HBA, VA 
and PCA constitute 81 % of the total BA concentration. 
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Analyzed BA concentrations were corrected according to creatinine levels and so y-axis 
values in the diagrams are presented as µg BA/mmol creatinine. Both volunteers showed 
increase in all BAs after MEDOX® consumption (Fig. 36 and Fig. 37).  
 
 
Figure 36. Increase in total BA content in urine after oral administration of MEDOX®,  
                  volunteer 1 
 
 
Figure 37. Increase in total BA content in urine after oral administration of MEDOX®,  
                  volunteer 2 
 
Volunteer 1 (Fig. 36) showed a major increase in VA which kept increasing even until the 
sixth hour after ingestion. Volunteer 2 (Fig. 37) also had higher amounts of VA excreted in 
the urine compared to the other 5 analyzed BAs, though not as much increase as volunteer 1 
and VA conc. started to decrease after 2 hours. This might have something to do with the food 
consumed by the first volunteer during the experiment most likely since the increase is so 
dramatic. This volunteer consumed food containing chocolate during the experiment and 
chocolate contain the flavoring agent vanillin which is also used in other foods, beverages and 
pharmaceuticals. Dietary vanillin is converted in the liver to the urinary metabolite VA in 
both conjugated and free form [54]. This is probably the reason for the drastic increase over 
time of this metabolite.  
 
All BAs increased for both volunteers compared to the start concentration measured for the 
urine before intake of MEDOX® (Table 19). HBA also increased and had its peak 
concentration 1 hour after consumption for both volunteers. This BA should not increase due 
to MEDOX® administration; however it could be a result from the normal diet of the 
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volunteers, or perhaps a metabolite of one of the other BAs.  
 
Table 19. Times for peak concentration of BAs in urine for both volunteers 
BA 
Volunteer 1 
(t=) 
Volunteer 2 
(t=) 
HBA  1  1 
VA  6  2 
PCA  3  2 
SA  3  2 
DHMBA  3  2 
GA  2  2 
 
There is an increase in all BAs for both volunteers indicating they are indeed metabolites of 
the anthocyanins in MEDOX®. There are some differences in which times the BA 
concentrations are highest when comparing the two. This could be due to difference in 
metabolism, or due to interference from other dietary components which are excreted as these 
BAs. The times are similar, 2 and 3 hours as time for peak concentration for most BA, 
whereas VA stands out from the rest. Stating an exact time for peak concentration is difficult 
because there was an hour between collections of each sample and it could occur right before 
or after one of these time periods.  
 
4.4.1.2 Oral administration of delphinidin-3-O-β-glucopyranoside 
 
Urine samples acquired from the male volunteer who was administered delphinidin-3-O-β-
glucopyranoside powder (500 mg of the compound) were made comparable by adjusting 
values to the total urinary volume at each time period. The urine samples were collected for 
an 8 hour period at each hour following consumption of the powder. The delphinidin 
anthocyanin is suggested to metabolize to GA. All BA was analyzed in the urine samples 
following administration of the powder, and there was observed increase in the concentrations 
of GA, SA and DHMBA (Fig. 38). Total excreted concentration of these three compounds in 
the 8 hour period was 2476.35 µg. 
 
 
Figure 38. Changes in total SA, DHMBA and GA concentration in urine after ingestion  
                  of delphinidin powder 
 
The volunteer did not ingest the anthocyanins malvidin and petunidin, which is suggested to 
metabolize into SA and DHMBA respectively. GA has three hydroxy groups in positions 3, 4 
and 5, DHMBA has a similar construction except there is a methoxy group in position 5 
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instead and SA has methoxy groups in position 3 and 5. By methylation GA could transform 
into the BA DHMBA by one methylation and SA by two methylation reactions. Since there is 
an increase in all these three BAs after consumption of delphinidin, this metabolic route might 
be a possibility. There has been evidence of demethylation of SA into GA [11]; therefore the 
opposite should also be a possibility.  
 
In research work done on gallic acid metabolism 3-O-methylgallic acid, 4-O-methylgallic 
acid and 3,4-O-dimethylgallic acid has been found [20, 55]. The first of those to metabolites are 
isomeric structures of DHMBA which would receive the name 5-O-methylgallic acid if it was 
named as a gallic acid metabolite. 3, 4-O-dimethylgallic acid has the same molecular formula 
as SA except SA has its methyl groups in third and fifth positions. A. Booth et.al identified 
SA as a metabolite of 3-O-methylgallic acid in 1959, and also 4-O-methylgallic acid as a 
metabolite of GA [56]. Since 3OMGA is a metabolite of GA it could be possible it metabolizes 
further to SA in that way since. DHMBA has perhaps not been considered a metabolite of GA 
since only 3OMGA and 4OMGA has been found. Nevertheless, what is not searched for is 
usually not found either.  
 
Since GA as well as SA and DHMBA increased in concentration in urine after administration 
of delphinidin-3-O-β-glucopyranoside, there is indeed a possibility that SA and DHMBA 
could be metabolites of GA.  
 
4.4.2 Plasma samples 
 
Distribution of free and total (free + conjugated) BAs in plasma before ingestion of 
MEDOX® /delphinidin powder is illustrated in Fig. 39. 
 
 
Figure 39. Free and total BA found in plasma before ingestion of MEDOX® 
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The numbers of which Fig. 39 has been based on are obtained by plasma analysis from 3 
volunteers. In plasma, similarly as in urine, HBA and VA are two of the BAs that are found in 
the largest portions compared to the rest of the BAs. In plasma however, GA which were only 
found in very small amounts in urine both in free and conjugated form, contributes to 61 % of 
the total concentration of the six BAs found in free form plasma. For total BA concentrations, 
GA accounts for 12 % of the total BA concentrations found of the six target compounds. 
 
Concentrations of free and conjugated BA in plasma are spelt out in Table 20: 
 
Table 20. Concentration of free BA and free + conjugated BA in plasma 
BA  Free BA (µg/L)  Total BA (µg/L) 
HBA  5.59 ± 2.39  107.56 ± 15.82 
VA  4.52 ± 2.36  47.60 ± 3.00 
PCA  0.65 ± 0.25   1.94 ± 0.46 
SA  1.06 ± 0.57  7.92 ± 1.24 
DHMBA  0.28 ± 0.19  0.84 ± 0.58 
GA  18.74 ± 7.88  22.61 ± 7.22 
 
Evaluating the concentrations in Table 20 gives reason to think that there is mostly BA in 
conjugated form in plasma. At least the three BAs HBA, VA and SA, seems to be mostly in 
conjugated form since their concentration of free compounds is very low. The BAs GA, 
DHMBA and PCA, however, do not have the same intense increase in concentration 
comparing free and total BA concentration. The compound in free form makes up for a big 
part of the total concentration, at least for GA where the free compound represents nearly the 
whole total concentration.  
 
4.4.2.1 Oral administration of MEDOX® 
 
BA concentrations in plasma samples from the two female volunteers were analyzed in a 6 
hour period to see if there would be an increase in the target compounds (Fig. 40 and Fig. 41).  
 
 
Figure 40. Total BA content in plasma 1, 2, 3 and 6 hours following oral administration  
                  of MEDOX®, volunteer 1 
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Change in BA concentration in volunteer 1 is presented in the figure above (Fig. 40) where 
the second diagram shows the four BAs of lowest concentrations to illustrate the change over 
time better. HBA exist in the highest concentration in plasma both before and after ingestion 
of MEDOX® capsules, since this BA is not believed to be a metabolite of any anthocyanin 
constituents in the product, it is likely caused by the regular diet or the metabolism of other 
substances. VA is also continuously increasing in plasma as it was in urine for this volunteer 
and can be explained by the same reason, that the diet is probably the cause. For DHMBA and 
GA there is a reduction in concentration from time zero and after consumption of MEDOX®. 
There is however an increase in SA which could indicate the possibility of this BA as a 
metabolite of GA and possibly also of DHMBA.  
 
 
Figure 41. Total BA content in plasma 1, 2, 3 and 6 hours following oral administration  
                  of MEDOX®, volunteer 2 
 
In the figure (Fig. 41) presenting total BA content in the plasma samples from volunteer 2, 
there is an increase in all BA. GA has a quite equal concentration throughout all the time 
period without much increase or decrease. The second diagram show only PCA, SA, 
DHMBA and GA because these BA is found in quite lower concentrations than VA and HBA 
and is thus presented in a better way in a diagram showing only these four. 
 
Peak concentration was reached at different times for the two volunteers for most BA except 
PCA and SA; all times are laid out in Table 21. 
 
Table 21. Time for peak total concentration of the BAs for both volunteers 
BA 
Volunteer 1 
(t=) 
Volunteer 2 
(t=) 
HBA  1  2 
VA  6  1 
PCA  2  2 
SA  1  1 
DHMBA  0  1 
GA  0  2 
 
SA has its first peak concentration time for volunteer at 1 hours after consumption, however it 
has a new peak with an even higher concentration at 3 hours even though there was a decrease 
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from t=1 to t=2, this new peak concentration could be the result of something the volunteer 
has consumed in the course of the experiment. If time zero is ignored for DHMBA and GA, 
their peak concentration is reached after 2 and 3 hours respectively. 
 
4.4.2.2 Oral administration of delphinidin-3-O-β-glucopyranoside 
 
Plasma samples given from the male volunteer who was administered delphinidin-3-O-β-
glucopyranoside powder were analyzed to observe change in BA concentration over a certain 
time period. The urine samples were collected for an 8 hour period following consumption of 
the powder. All BA was analyzed in the urine samples even though GA is the suggested 
metabolite of delphinidin. SA and DHMBA was found in increased levels in urine after 
delphinidin administration and are also interesting to evaluate in plasma. Changes in 
concentrations of GA, SA and DHMBA are presented in Fig. 42 below.  
 
 
Figure 42. Changes in total SA, DHMBA and GA concentration in urine after ingestion  
                   of delphinidin powder  
 
SA was the only BA which was found in a higher concentration after intake of delphinidin 
even though GA is the main metabolite in this case. This adds to the idea that SA could be 
metabolized from GA. That neither DHMBA nor GA is found in increasing amounts is 
curious and does not agree with the results analyzed for urine. Similar tendencies of analyzed 
GA and DHMBA concentrations could also be observed in the two other volunteers who were 
administered MEDOX®.  
 
4.4.3 Summary and comparison of urine and plasma results 
 
GA and PCA should be the most abundant BA metabolites after supplementation of 
MEDOX® theoretically since they are the corresponding metabolites of delphinidin and 
cyanidin, respectively, which are the main constituents of the product. However, based on the 
obtained results, VA and HBA are the two BAs found in highest concentrations in urine as 
both free and conjugated acids both before and after intake of MEDOX®, in plasma GA is 
actually one of the BAs found in highest concentrations both before and after intake. VA and 
HBA as the main BAs found excreted in urine is corresponding to what Nurmi et al. found in 
their research after ingestion of an oregano extract which contains many of the same 
compounds [15]. They however, did not detect gallic acid in the urine after supplementation 
even though it was expected. GA was again failed to be found in a new research project 
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published by the same group in 2009 where delphinidin glycosides were the main AC in their 
bilberry-lingonberry purée [10]. In the results from this utilization part of the thesis, GA was 
found in urine both in free and conjugated forms in urine after administration and in 
increasing amounts from before intake though not in vast amounts.  
 
Nurmi et.al[10] suggested that GA was metabolized further to SA by methylation, which could 
indeed be the case. Studying the trend of increase in urine following oral administration of 
MEDOX® SA is increasing in much higher concentrations than GA, which somehow seems 
odd since malvidin is not found in the same amounts in MEDOX® as delphinidin. The SA 
increase observed could very well be the result of GA methylation and as a metabolite of the 
malvidin anthocyanin. In plasma, however, GA is found in larger quantities than SA although 
GA is decreasing after intake. Since SA increase after intake in opposite of GA, this could 
also be an indication of transformation of GA to SA. Also seeing that DHMBA is found in 
small concentrations and sometimes also decrease after intake could suggest that also this BA 
undergo methylation to SA to some extent. DHMBA however, is not the metabolite of one of 
the main constituents in MEDOX® and should therefore not be retrieved in the same degree 
as GA after ingestion. The experiments analyzing BAs in both urine and plasma after intake 
of delphinidin powder support the idea of GA metabolizing to SA and also to DHMBA. 
 
PCA is not found in very high amounts in whether urine or plasma after intake, just like GA. 
In urine it is found in higher concentrations than GA but in plasma the numbers are turned. 
VA and HBA are the main constituents excreted in both urine and plasma and are found in the 
highest amounts. VA could be a metabolite of PCA by methylation, and that could explain the 
reason for the drastic increase in VA after intake of MEDOX®. It is also suggested that HBA 
is metabolized from PCA; this would happen if PCA lost a hydroxy group. Similar tendencies 
of BA findings have been described by Nurmi et.al in 2006 after oregano extract ingestion. 
They have also stated that small amounts of HBA have been found in rat urine after been 
given PCA [15]. This could also explain why increase in HBA concentration has been observed 
after ingestion of the supplement, even though pelargonidine which is its corresponding AC is 
not found in MEDOX®.  VA is the main constituent found in urine and HBA in plasma, these 
are also the cases before consumption of the AC rich product. 
 
The overall distribution of BAs in plasma and urine correspond to each other, except that GA 
is found in higher concentrations in plasma than in urine compared to PCA, SA and DHMBA 
which also correspond to the figures showing distribution of BAs in urine and plasma before 
ingestion of supplements. It seems as though they increase corresponding to that model, 
which is also true for the main BA constituents found in both urine and plasma before and 
after intake. BAs are also found in lower concentration in plasma than in urine. This could be 
explained by the fact that the urine is “stored” in the body for a while before it is excreted and 
thereby the compounds are allowed to up concentrate and the concentrations are thus higher 
here. 
 
Total excreted concentration of BAs in urine and plasma seem to be quite low in comparison 
to the ingested amount of ACs which is 80 mg per MEDOX® capsule. There is however an 
increase in BA after intake of these capsules suggesting that these compounds really are 
metabolites of their corresponding ACs. Excretion of BAs in the 6 hour period following 
intake of MEDOX® was ~ 2 – 3 mg in urine. The excretion of these metabolites probably 
continues a while longer adding to the concentrations but the peak concentration is mainly 
after 1-2 hours in plasma and 1-3 hours in urine for the BAs. 
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Because ACs and also BAs alone are found in other dietary sources than the supplements 
given the volunteer subjects, all BA excreted is probably not due to MEDOX®. However, the 
increase propose metabolism of the ACs in MEDOX® to their corresponding BAs which was 
the aim to observe by applying the developed method in this thesis. The results even suggest 
further metabolism between the BAs themselves into each other by either methylation or loss 
of a hydroxy group. Total concentration of excreted BAs GA, DHMBA and SA increased 
from < 20 % to 54.3 % in urine and 82.9 % in plasma following administration of delphinidin 
which only strengthen the ideas about BA metabolism. Increase in BA concentration in 
plasma and urine after intake of MEDOX® due to the existing (very low) BA concentrations 
in the capsule is unlikely but cannot be excluded. 
 
HBA, VA and SA increase most in free to total concentration in plasma, suggesting these are 
found mostly in conjugated form. In urine all BA increase quite much in concentration 
considering free and conjugated compounds suggesting the majority of BAs in urine are 
conjugated. GA and DHMBA are the two BAs that show the least difference in increase from 
free to total concentration of BA. 
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5. Conclusion 
 
A robust analytical method consisting of sample preparation and a chromatographic method 
was developed with good recovery (%) results for all six BA analyzed. LLE was chosen as the 
best sample extraction technique with ethyl acetate as extraction solvent. Derivatization of all 
samples, with BSTFA as derivatization reagent and the addition of 25 % acetonitrile as 
derivatization catalyst, was performed on all samples prior to analysis by GCMS. GCMS 
proved to be an accurate and fitting analytical separation and detection combination with 
achieved low limits of detection and quantification for all target compounds. A linear standard 
calibration curve was prepared with two deuterated internal standards with the same BA 
structure as GA and HBA, to be able to quantify the BAs. The finished analytical method for 
identification and quantification of the six BA yielded good results for all compounds (Table 
22). Linearity range is given as the highest concentration for each BA that was implemented 
in the calibration curve for linearity, and recovery results are for non-enzyme treated samples. 
  
Table 22. Analytical characteristics of BAs given the method for the GCMS analysis 
BA 
Recovery % 
(urine) 
Recovery % 
(plasma) 
Linearity 
(R2) 
Linearity range 
(µg/L)  LOD (µg/L)  LOQ (µg/L) 
HBA  89 ± 5  57 ± 3  0.996444  1405.22  0.514 ± 0.127  1.706 ± 0.223 
VA  100 ± 5  105 ± 5  0.997416  1175.27  0.479 ± 0.106  1.548 ± 0.240 
PCA  95 ± 4  63 ± 3  0.991396  1385.97  0.531 ± 0.062  1.984 ± 0.798 
SA  105 ± 6  139 ± 7  0.998321  1085.22  1.155 ± 0.169  3.280 ± 0.296 
DHMBA  94 ± 6  64 ± 6  0.998191  1058.22  0.267 ± 0.028  1.048 ± 0.161 
GA  121 ± 4  80 ± 3  0.990978  827.31  0.486 ± 0.027  2.676 ± 0.106 
 
Identified BAs increased in quantity compared to baseline excretion, which suggest the 
absorbed AC compounds in MEDOX® were extensively metabolized to their corresponding 
BAs. Further metabolism resulting in certain BAs metabolizing to other BAs were also 
discussed due to interesting observations. GA is suggested to metabolize to SA and DHMBA 
by methylation, and PCA is suggested to metabolize to VA and also HBA. HBA is observed 
in increased amounts after intake of MEDOX® even though the parent compound of 
pelargonidine is not found in the product, which could be explained by the possible metabolic 
pathway from PCA.  
 
HBA and VA are seen as the major BA constituents in both urine and plasma, GA is also one 
of the most abundant BAs found in plasma. In both matrixes before ingestion of MEDOX® or 
delphinidin powder, HBA and VA are still the most abundant BAs; however small amounts of 
the remaining BA are also found in both free and conjugated form. From the results, it seems 
that BAs are mostly in conjugated form in urine, and HBA, VA and SA are mostly found as 
conjugated compounds in plasma, but the concentrations of GA, PCA and DHMBA do not 
increase much by enzyme treatment.  
 
The conclusion of this thesis work suggests that ACs in MEDOX® metabolize into their 
corresponding BAs. This is based on increased levels of all BA after supplementation, 
however one cannot say with full certainty that the increase originates exclusively from the 
intake of MEDOX®/delphinidin powder based on variety in results in addition to no diet 
restrictions for most volunteers. An idea for further research is to apply strict diet restrictions. 
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The obstacle of applying such restrictions is the abundance of ACs in food and their 
widespread nature. Study of absorption and metabolism of these compounds is challenging 
because a number of parent compounds usually convert into an assortment of metabolites. 
Since the BA metabolites are excreted relatively fast after ingestion, their antioxidant effect is 
most probably of a brief nature as well. They are also most likely absorbed in the small 
intestine due to their rapid excretion. 
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Appendices 
 
Appendix 1. Concentrations of stock solutions 
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Appendix 2. Standard calibration curves 
  
Standard calibration curves and curve information for each BA: 
 
HBA: 
0.0 1.0 2.0 3.0 4.0 5.0 6.0 Conc. Ratio
0.00
0.25
0.50
0.75
1.00
1.25
Area Ratio(x10)
 
 
VA: 
0.0 1.0 2.0 3.0 4.0 5.0 Conc. Ratio
0.0
0.5
1.0
1.5
2.0
2.5
3.0
Area Ratio
 
 
PCA: 
0.0 1.0 2.0 3.0 4.0 5.0 6.0 Conc. Ratio
0.0
1.0
2.0
3.0
4.0
5.0
6.0
7.0
8.0
9.0
Area Ratio
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SA: 
0.0 1.0 2.0 3.0 4.0 5.0 Conc. Ratio
0.00
0.25
0.50
0.75
1.00
1.25
Area Ratio
 
 
DHMBA: 
0.0 1.0 2.0 3.0 4.0 5.0Conc. Ratio
0.0
1.0
2.0
3.0
4.0
Area Ratio
 
 
GA: 
0.0 2.5 5.0 7.5 Conc. Ratio
0.0
1.0
2.0
3.0
4.0
5.0
6.0
Area Ratio
 
 
* The tenth calibration standard was eliminated to make GA’s standard curve more linear.  
   R2 = 0.990978.  
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Scans of the standard calibration curve printouts from the GCMS post analysis 
program: 
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Appendix 3. Preparation of standard solutions and their concentrations 
 
Preparation of standards: 
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Concentration of standards: 
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Appendix 4. Instrumental settings, GCMS 
 
GC: 
Column oven temperature: 50 ºC 
Injection temperature: 280 ºC 
Injection mode: Splitless 
Sampling time: 1.00 min 
Carrier gas: Helium (He) 
Primary pressure: 500 - 900 
Flow control mode: Linear velocity 
Pressure: 122.7 kPa 
Total flow: 32.3 mL/min 
Column flow: 1.40 mL/min 
Linear velocity: 35 cm/sec 
Purge flow: 3.0 mL/min 
Split ratio: 20.0 
 
Column: 
Name: Factor Four/ CP-SIL 8 CB-MS 
Film thickness: 0.25 µm 
Length: 50 m 
Inner diameter: 0.25 mm 
 
MS: 
Ion source temperature: 240 ºC 
Interface temperature: 300 ºC 
Solvent cut time: 7 min 
Start time: 7 min 
End time: 42 min 
Acquisition mode: SCAN/SIM 
Event time: 0.15 sec 
Scan speed: 3333 
Start m/z: 70 
End m/z: 500 
 
Ionization method: EI 
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Appendix 5. Mass spectra of all benzoic acids and internal standards 
 
Benzoic acids: 
 
Gallic acid (GA): 
 
 
Protocatechuic acid (PCA): 
 
Vanillic acid (VA): 
 
DHMBA: 
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Syringic acid (SA): 
 
HBA: 
Internal standards: 
 
HMBA: 
 
 
d-Gallic acid (d-GA): 
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d-HBA: 
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Appendix 6. Poster presenting sample preparation, admitted to 
“Kromatografisymposiet” in Sandefjord 2010 
 
 
